People

then spent three years at JPMorgan Chase as a VP of Product in the global blockchain team, where he led the development of real-life financial use cases for the bank. Most recently, he founded and ran

Before Team8, Shirly worked for 5 years as a Strategy Manager at Deloitte, leading consulting projects for private and public sectors and advising C-level executives. Before that, Shirly worked as a Data Analyst at the Israeli Ministry of Finance. Shirly began her career as an Intelligence Platoon Leader in the 8200 Unit and holds a B.A in P.P.E. (Philosophy, Politics, and Economics) from the Hebrew University of Jerusalem.

Sharon brings strategic and business experience from her two years as a consultant at Shaldor, where she advised numerous government agencies (e.g., the MoJ and PMO) and large private enterprises on growth and M&A strategies. Additionally, Sharon interned as a public sector strategy advisor at EY, where she closely supported the MoE in an education reform. She holds a BA in PPE from Tel Aviv University.

She has held CEO, CFO, chairperson, and board member roles for multiple hi-tech companies, and has more than 26 years of investment and operational experience across Silicon Valley, New York, and Tel Aviv.

Ruthie has joined us from Made Finance, where she worked for the last 8 years as Head of VC financial services. At Made Finance, she managed to help entrepreneurs to build and grow successful funds by providing the financial and operational expertise necessary to achieve their goals. Prior to that, Ruthie worked as a Director of Finance at SZ Accounting & Financial Consulting firm. Ruthie holds a B.A. in Accounting & Finance from the Hebrew University of Jerusalem.

He is responsible for Team8’s Platform, an essential part of our unique venture fund model that means our team work to develop, sell, hire for, and expand our portfolio companies’ businesses, driving their success.

Before joining Team8, Ronen co-founded eToro, a financial unicorn that serves 31M users in more than 100 countries and has pioneered a social investing model. He served as the company’s Chief Product Officer and managed product and engineering, and since January 2020, has been a board member and non-executive director. Prior to this, Ronen designed products ranging from medical devices and household appliances to numerous desktop and web applications.

Rinat has extensive experience in global financial management. In her previous role as Director of Finance at Yotpo, she led a team of 14 and successfully managed complex financial landscapes across multiple jurisdictions.

Reut brings significant experience in Healthcare and over 5 years of experience in data analysis to the team. She previously worked at Precision Advisors in London, where she specialized in life science regulations, market access, and pricing. Before moving to London, she worked at the Prime Minister’s Office as a data analyst. Reut holds a BSc in Biology and Biotechnology from Tel Aviv University and an MSc in International Health Policy from the London School of Economics (LSE).

Peleg is part of the venture creation team at Team8, where he works with founders and venture teams to turn deep technical ideas into sharp positioning, market narratives, and go-to-market strategy across cybersecurity and software infrastructure.

Before joining Team8, Oron worked as a manager at Ernst & Young Strategy and Transactions department, where he led financial and accounting due diligence processes for leading VC’s, PE’s and strategic corporate buyers in cross-border M&A and investment transactions.

Before joining Team8, Ori was the CRO and a founding member of Own (acquired by Salesforce). Under his leadership, Own’s ARR grew over 100% year over year to more than $170M and over 800 employees. He led a variety of functions including sales, customer success, sales development, operations, and alliances. Prior to this, he worked at Boston-based OpenView Venture Partners on a variety of go-to-market initiatives, including two years on Intronis (acquired by Barracuda Networks).

Nufar is Team8’s VP of Operations. Her mission is to support the growth of Team8 by implementing working models and adoption of new tools. She focuses on real estate, operations, community and welfare, that’s in order to empower the cross functional teams.

Prior to joining Team8, she worked at the Bank of New York (BNY), contributing to the firm’s rapid transformation, including roles in strategy and product innovation. She holds a BA in Economics from the University of Pennsylvania.

Noam brings with her a unique combination of experience in both administration and recruitment. She spent nine years at the Ministry of Defense as an Executive Assistant to senior officials, a role that demanded discretion, agility, and the ability to manage complex workflows. In recent years, she transitioned into recruitment, with a focus on analytical roles, and is now excited to return to the EA position she’s passionate about.

Noam joins Team8 from Alice (formerly ActiveFence), where she served as Director of Brand Strategy and Engagement for nearly four years. In that role, she led the company’s brand strategy and engagement efforts, including its recent rebranding. Prior to Alice, Noam was a media advisor at BBDO and served for over seven years in the IDF Spokesperson’s Unit, primarily as an officer.

Noa Zamir is the Payroll Specialist at Team8. For the past 2.5 years, She has worked as a payroll expert at Guberman Consulting with approximately 25 companies per month, taking care of all their payroll needs. Noa holds a bachelor’s degree in sociology and East Asia studies from Tel-Aviv University. She spent 8 months in China teaching kids English, touring the country, and practicing her Chinese. In her spare time, she enjoys traveling, puzzle solving, and making desserts as a reminder of her past as a pastry chef.

Before joining Team8, Noa served as a Chief of Staff to the CEO in a SaaS B2B fintech start-up, playing a focal role in ensuring the smooth running of the organization towards achieving its strategic goals and objectives, working with the executive leadership team to develop and implement strategic business initiatives. Prior to that, she was an Operations Manager at a Single-Family Office where she oversaw the day-to-day operations and managed investment execution across various legal structures, coordinating multiple teams and stakeholders.

With a background as an Occupational Therapist in the pediatric rehabilitation department at Sheba Hospital, Nitzan dedicated her career to helping individuals overcome challenges and reach their potential. Now, She’s made a shift to bring that same commitment to supporting people in the workplace here at Team8.

Nitay co-founded ActionIQ, the enterprise Customer Data Platform (CDP) that pioneered a new category in marketing technology. As CTO, he architected the platform end-to-end, scaled the company from inception to hundreds of employees, and helped grow it into a category leader serving Fortune 500 clients. ActionIQ raised $145M from Sequoia Capital and Andreessen Horowitz (a16z) and was acquired in 2025.

He brings extensive strategic and business expertise from his three years as a strategy consultant at Shaldor, leading projects for private and public sectors and advising C-level executives.

Natali is a bookkeeper at Team8. Previously, Natali worked at Biscience, a startup company and Leo Schachter Diamonds. Natali holds a B.A in Mathematics from the University of Kazakhstan and Type 3 in Bookkeeping in Israel.

Mor brings a strong operational background and extensive experience supporting fast-paced teams. Over the past several years, she worked at Leal Health, an AI-powered healthcare platform, where she was deeply involved in day-to-day operations, internal coordination, onboarding, and process improvement- helping create structure, clarity, and a positive working environment.

Michelle is the Head of IR and oversees capital development across all Team8 funds. She has nearly 20 years of experience in the financial industry managing investor relationships, legal negotiations, and helping to structure financial vehicles.

Before joining Team8, Michael spent 37 years serving in the US Navy, where he rose to the rank of four-star admiral. He held positions focused on cyber, intelligence, maritime operations, and maritime security, culminating in a four-year tour as commander of the US Cyber Command and Director of the NSA. His extensive service included duty with the Chairman of the Joint Chiefs of Staff, the Joint Chiefs of Staff, and US Indo-Pacific Command. He commanded at the unit, fleet, and service component levels in the Navy.

Michael is a fintech analyst at Team8, where he leads research and analysis, contributing to the ideation, validation, and company-building process. Michael also provides strategic support for existing fintech portfolio companies. Prior to joining Team8, Michael was a consultant at KPMG Israel, where he specialized in fintech projects for major financial institutions in Israel. He is also a financial literary coach. Michael holds a B.A. in Economics and Business Administration from the Hebrew University of Jerusalem.

A seasoned GTM executive, he has held senior roles at VMware and FireEye, as well as multiple VC-backed companies that achieved successful exits. With broad expertise in cybersecurity, he excels at driving organizations to build high-performing sales teams, instilling sales process discipline, and developing differentiated, prescriptive, and cohesive selling models, regardless of company stage.

Maayan holds a BSc and MSc in Electrical Engineering, with expertise in machine learning and reinforcement learning. His deep theoretical foundation, combined with hands-on industry experience, bridges cutting-edge AI research and real-world applications.

Before joining Team8, Julietta worked for six years as a Bookkeeper at Zerto, and prior to that, she was part of the finance department at Union Motors Ltd.

Julia is a Business Development Operations Specialist at Team8, where she supports portfolio companies in building and executing go-to-market strategies across digital health. She works closely with founders and leadership teams to drive targeted outreach, streamline operations, and accelerate growth.

Jonathan was part of the Sales Development team at Cato Networks, focusing on the Belgian market and targeting large enterprise accounts. He specialized in outbound initiatives and was consistently recognized as a top performer.

Jessica is a full-stack marketer with over 12 years of marketing-for-tech experience. Jessica serves as product marketing manager at Team8 where she is responsible for overseeing the marketing strategy and execution for the group’s Digital Health Foundry and Digital Health portfolio companies. Throughout her career in the Israeli startup scene and in the tourism industry, Jessica has held numerous marketing roles across varied verticals.

He leads Team8’s innovation strategy, driving new growth opportunities and working closely with founders to build category-leading companies. As well as contributing to Team8’s overall processes and needs, Israel has a particular interest in ideating and building groundbreaking companies in the Digital Health space.

Ilya is a seasoned technology leader with extensive experience in artificial intelligence, cybersecurity, and cloud infrastructure. Over the years, he has helped leading organizations design and implement secure, scalable solutions that drive innovation and long-term impact.

Prior to joining Team8 Capital, she worked as an Office Manager and Personal Assistant to the Managing Director at Houlihan Lokey, an investment bank. Before that, Hilla spent three years in Rome, Italy, and two years in Manila, Philippines, working for the Israeli Embassy while indulging her love of scuba diving and exploring Asian cuisine.

As the Security & IT Tech Lead at Team8, Guy Elias is the leader for the organization’s Security and IT functions. His responsibilities encompass overseeing cloud security, managing enterprise infrastructure, and handling all day-to-day technology operations.

At Team8, Gilad works with our portfolio companies on the part that usually takes founders the longest: getting in front of the right enterprise buyer. Design partners, first customers, the CTO who has the exact problem you solve. I run the intro, prep both sides, and stay involved until something real happens.

She supports founders with the ideation, building, and scaling of their businesses. As well as financial expertise, Galia has experience with B2B sales methodologies and intrapreneurship.

Gal began her career at the U.S. Embassy, where she spent three years working in the Security Division, including at the Ambassador’s Residence. Most recently, she worked at Pagaya as an Executive Assistant to two VPs in different departments. She is currently studying Political Science and International Relations at the Open University.

Eyal is a Data Scientist and product leader with over 15 years of experience. He is co-founder and CTO of Zone7 Technologies (acquired by SVEXA), a pioneering AI platform optimizing the performance and longevity of world-class athletes. At Zone7, he developed AI-based injury risk forecasting from concept to a premium product used by elite organizations across the NBA, NFL, EPL, and beyond, overseeing all R&D, product, and CS operations.

Eviatar is an IT Manager in the Team8 IT department. Prior to joining Team8, Eviatar worked as a system admin for over 10 years at cybersecurity companies, including at Insights and Madsec. Eviatar was a medic and fighter in the Israeli Artillery Corps. He holds both MCSA & CCNA certifications.

She also served in Israel’s elite 8200 unit and later continued with permanent service in the Israeli Air Force, building strong operational skills and a can-do mindset.

He has over 15 years of experience in cybersecurity and applied data science, and has worked closely with public and private sector leaders to solve security and data challenges.

Demetrios previously served as Chief Executive of the Medicare program at the Centers for Medicare & Medicaid Services. He was a Senior Executive for Medicare at UnitedHealthcare, and served as Deputy General Counsel and then Associate Deputy Secretary at the US Department of Health and Human Services where he played a leading role across the department’s agency portfolio, including the Food and Drug Administration, Office for Civil Rights, and Office of the National Coordinator for Health Information Technology. He also built practices at two leading healthcare law firms.

Before joining Team8, Dekel worked for five years as a Controller at Zerto. Prior to that, she completed her internship at Ernst & Young in the High-Tech department.

Before joining Team8, Daniel led Israeli venture strategy for the George Kaiser Family Foundation (GKFF), where she built and managed the foundation’s dedicated investment activity in Israel across sectors including cybersecurity, AI, and digital health. In that role, she sourced and led investments in companies such as Guardz, Gem Security (acquired by Wiz Security), and Sensi.AI, while cultivating deep partnerships with founders, funds, and corporate stakeholders.

Before joining Team8, Chen worked in various financial positions in a Private Equity fund. Prior to that, Chen was a manager in the audit department at Ernst & Young, specializing in VC clients.

Before joining Team8, Carin spent 4 years as a Manager at PwC Israel, in the Management Consulting team, specializing mostly in IPO readiness and general support as well as scale up & innovation, with extensive project and change management experience.

Bar brings a unique blend of community leadership, strategic partnerships, and business development to Team8. He is responsible for leading the firm’s industry relations, building and managing strategic partnerships, and expanding Team8’s global community of entrepreneurs, executives, and ecosystem leaders.

Before joining Team8, Ayala spent three years at Payoneer. Her most recent role was Strategy & Operations Manager in the Chief of Staff Office, where she led global cross-functional strategic initiatives and high-impact projects. Before that, Ayala served as a Business Operations Process Manager, driving scalable process design, operational efficiency, and customer-journey improvements for high-value clients.

Aviv is Team8’s VP of HR. Her mission is to hire the best talents to create and build Team8’s new Cybersecurity, Data Science, Fintech, and Digital health companies. Aviv has vast experience in HR & Talent Acquisition in the Hi-tech industry. Aviv holds a B.A degree in Management & Human Resources and an M.B.A from Ben-Gurion University.

Aviv has extensive experience in digital marketing and will help our companies with growth efforts. On the group level, Aviv will lead our marketing operations, digital assets, and also strategic partnerships.

Over the past several years, Assaf has built partnerships across Israel’s global tech and innovation ecosystem, most recently as Head of Partnerships at Tech1 Conference, and previously at Future Summit and EcoMotion. Earlier in his career, he worked at Israel’s Ministry of Foreign Affairs, including a posting at Israel’s Mission to the United Nations in New York.

With more than 25 years of experience in cybersecurity and technology, he formerly served as Team8’s CTO. He now uses his extensive experience and access to talent to play a critical role in ensuring the success of our founding teams and startups, and has so far established and scaled over a dozen companies.

Most recently, Asaf led the onboarding of financial partners at Pagaya, a leading fintech company providing AI-powered credit analysis capabilities. In this position, Asaf worked with banks, fintech, lenders, and credit card issuers to help them grow their business by connecting to Pagaya’s network and utilizing its credit analysis technology. Before Pagaya, he held multiple roles at Via, the TransitTech startup, where he worked with cities, governments, and private corporations to launch and scale technology-enabled smart transportation services globally.

At Team8, Asaf leads global marketing and positioning across the fund and its portfolio companies. Working within Team8’s unique model, which combines an in-house company-building team with a global network of C-level executives known as the “Village,” he partners with founders from inception to launch and growth – shaping strategy, narrative, product marketing, go-to-market architecture, and brand design to transform disruptive ideas into market leaders.

Amit holds a bachelor’s degree in law from The College of Management Academic Studies and completed her internship in commercial and civil litigation at Arnon, Tadmor-Levy.

Amir managed a team of high-level researchers and developers in an elite IDF cyber unit. He holds more than 10 patents, most of which are for cybersecurity products.

Before joining Team8, Amir held positions in companies such as AiVF,AI solution for IVF where he was Chief Commercial Officer, and Inspire, one of the largest patient-focused social networks) where he was a Co-founder.

He brings extensive strategic and business expertise from his two years as a senior strategy consultant at Strategy& by PwC, leading projects for private and public sectors and advising C-level executives.

He has more than two decades of experience, and is passionate about leveraging performance marketing, data, and technology to drive sustainable company growth. His expertise lies in disruptive growth hacking, software architecture, AI analysis, and big data.

I worked as a personal assistant to the CEO at Flying Tiger Copenhagen for three years. I’m currently based in Rishon LeZion. I love traveling, exploring new places, and reading. I’m a good listener and always happy to help those in need.

Adi is Team8’s HR & Talent Acquisition Specialist. Her mission is to hire the best talents to create and build Team8’s new cybersecurity, data, and fintech companies. Formerly Talent Acquisition Specialist at Innovid and Recruitment Team Leader at See.V. Adi holds a B.A degree in Management & Human Resources and an M.B.A specialized in Organizational Behavior & Development.

Chuck joined MassMutual Ventures in 2015 and is charged with sourcing new investment opportunities and portfolio management. Recently, Chuck was promoted to partner, and as an expansion of his role, has joined our Climate Tech Fund. He brings his decade of venture experience within fintech and enterprises SaaS to the fund, and will look to source opportunities within climate insurance, carbon finance, and the blue economy, among others.

Doug has served as Managing Partner and Head of MassMutual Ventures since its formation in July 2014. He joined MassMutual in 2007 as Senior Vice President and Chief Financial Officer for the Retirement Income business unit. From 2009 through 2016, he served as the company’s Senior Vice President of Strategy and Corporate Development.

Christine joined the team in the fall of 2015 as MMV's Executive Liaison. She is responsible for managing daily operations, which includes onboarding new hires, invoicing, and fully supporting the US's three managing directors. Previously, Christine served as Executive Assistant for senior executives at McKinsey & Company, The Parthenon Group, EY, and Bain Capital. She holds a BS from Eastern Nazarene College. On her down time, Christine spends time with family and friends. She is an avid sailor who enjoys cruising the New England coastline.

Tim joined MassMutual Ventures as Managing Partner in 2023 and leads the Climate Technology Fund. Prior to MMV, he was a Managing Director at Equinor Ventures and served on the boards of several portfolio companies, including Commonwealth Fusion Systems, Mainspring, SkySpecs, and Sunverge. His previous positions at Equinor included CEO Advisor, Corporate Strategy Manager, and Business Development Manager. Earlier in his career, Tim held research and consulting roles at Cambridge Energy Research Associates (now part of S&P Global), the Oxford Institute for Energy Studies, and Google.

Kara Burns is a Senior Associate with the Climate Technology Fund. Kara started her career in Fidelity’s equity research department. Most recently, she was a Sector Specialist on the private placements team, Fidelity’s late-stage VC and cross over investing arm, where she contributed to recommendations representing over $1B in capital deployed. Prior to this, she worked on the ESG, consumer, and strategic advisors teams.

Adina Safer is a seasoned healthcare strategist and creator of The Medicaid Sessions. Her expertise in digital health and Medicaid enables her to develop innovative healthcare solutions. Safer’s unique value lies in her ability to create engaging educational content and strategies for healthcare improvement. Advisor to Reach Capital focused on healthcare strategy, Medicaid and digital health. She created The Medicaid Sessions and works on healthcare educational content and strategy. Her outside affiliations are context for the advisory role, not Reach employment.

Arjun Singh is CEO and Co-founder of Superconductor. He is also the Co-founder and former CEO of Gradescope, which was acquired by Turnitin, where he later served as Chief Strategy Officer. He holds a Ph.D in Computer Science from UC Berkeley where he taught artificial intelligence. Advisor to Reach Capital. He co-founded Gradescope, subsequently acquired by Turnitin, and later served as Turnitin’s Chief Strategy Officer. His current biography identifies him as CEO and co-founder of Superconductor. He earned a Berkeley computer-science doctorate and taught artificial intelligence.

Julia Bernstein serves as the Chief Operations Officer at Brightside Health, where she leads strategy and operations to expand the company’s virtual mental health care services. With extensive experience in behavioral and digital health, she has a background in payer sales, startup operations, and nonprofit strategy. Bernstein’s unique value lies in her ability to scale healthcare operations and drive growth in critical areas like mental health. Advisor to Reach Capital with experience in behavioral and digital-health operations. Her biography describes leading strategy and operations at Brightside Health and prior work in payer sales, startup operations and nonprofit strategy.

Rob Purinton is the Chief AI Officer at AdventHealth. His experience in AI and healthcare positions him as a leader in leveraging technology to improve healthcare outcomes. Purinton’s unique value lies in his ability to develop and implement AI-driven healthcare solutions. Advisor to Reach Capital with expertise in healthcare artificial intelligence. His published biography identifies him as Chief AI Officer at AdventHealth, supporting development and implementation of healthcare AI solutions. This outside-employer title is not treated as a Reach officer role.

Dr. Hannah Galvin is the Chief Health Information Officer and interim Chief of Pediatrics at Cambridge Health Alliance, and holds faculty appointments at Harvard Medical School and Tufts University School of Medicine. A nationally recognized leader in clinical informatics, she co-founded the equitable interoperability task force Shift, serves on the federal Health IT Advisory Committee, and champions patient-driven data sharing. Her focus on adolescent health, child abuse medicine, and vulnerable communities underscores her commitment to delivering equitable, patient-centered care. Advisor to Reach Capital and a physician focused on clinical informatics and adolescent health. Her published biography identifies leadership at Cambridge Health Alliance and faculty affiliations with Harvard and Tufts. Her work includes equitable interoperability and patient-driven health-data sharing.

Stuart brings more than two decades of engineering and product leadership experience. Most recently, he was Chief Technology Officer at One Medical, where he led the technology organization through rapid growth, IPO, the acquisition of Iora Health, and integration into Amazon. Before that, he co-founded Rise, a digital health startup offering personalized coaching, which became One Medical’s first acquisition. Earlier in his career, Stuart helped shape the early internet at Mozilla and Netscape. Advisor to Reach Capital with engineering and product-leadership experience. He formerly led technology at One Medical through its IPO, Iora Health acquisition and Amazon integration. Earlier he co-founded digital-health coaching company Rise and worked at Mozilla and Netscape.

David Landman is a former Global Head of Talent Development at Goldman Sachs and currently an HR Executive and startup advisor. His experience in talent development positions him as a leader in enhancing organizational capabilities. Landman’s unique value lies in his ability to advise startups and drive talent growth strategies. Advisor to Reach Capital and a human-resources executive with experience in talent development. Formerly Global Head of Talent Development at Goldman Sachs, he supports startups and advises on workforce capabilities.

Guillermo Miranda is a former Chief Learning Officer at Boeing and IBM, now co-founder of Atlas Copilot. He specializes in learning and development, leveraging his experience to drive innovation in corporate settings. Miranda’s unique value lies in his ability to create impactful learning platforms. Advisor to Reach Capital. His background includes chief learning officer roles at Boeing and IBM and co-founding Atlas Copilot. He focuses on corporate learning platforms and organizational development.

Gordon Trujillo is the VP, Head of Learning and Development at DaVita Kidney Care. His experience in L&D positions him as a leader in creating effective learning programs. Trujillo’s unique value lies in his ability to develop and implement learning strategies that enhance organizational performance. Advisor to Reach Capital with expertise in workforce learning and development. His biography describes leadership of learning and development at DaVita Kidney Care and experience designing programs that support organizational performance.

Prakash is a physician-operator with experience spanning clinical training, startup formation, and large-scale healthcare leadership. He trained in orthopedic surgery before helping spin out a half-dozen pharma and device companies, then spent years running major health organizations. At GuideWell he served as COO and President, helping scale the company past $20B in revenue. At Elevance (formerly Anthem), he grew the Diversified Business Group 6X in three years and led a behavioral health transformation from under 1% digital to over 30%. Advisor to Reach Capital and a physician-operator with experience in company formation, payer operations and specialty care. His biography describes prior leadership at GuideWell and Elevance and an interest in value-based chronic-condition care. The directory’s external employer captions are not treated as Reach executive titles.

Advisor to Reach Capital with three decades of academic health-system experience. His published biography describes leadership at Stanford Medicine Children’s Health and prior operations roles at Women & Infants Hospital, St.Louis Children’s Hospital and Barnes-Jewish Hospital. He supports founders working in pediatric, women’s and hospital care.

From a young age, Shauntel understood the transformative power of education. From her time at MIT studying chemical engineering to completing her MBA and MA in Education at Stanford, she’s navigated life with a curious mind and an insatiable appetite for knowledge. Shauntel set out to instill this same love for learning in others through volunteer tutoring and mentoring programs. She is also a health enthusiast and understands that a healthy mind and body are essential for learning and thriving. Co-Founder Emeritus of Reach Capital, as explicitly designated by the current directory. She studied chemical engineering at MIT and earned Stanford graduate degrees in business and education. Her prior Reach investment work supported learning and health companies. The emeritus designation does not imply a current active partner role.

Office Manager at Reach Capital. She studied advertising and women and gender studies at the University of Oregon, began her career as an art director in New York and subsequently moved into office management and event planning.

Designer at Reach Capital. She studied communication design, psychology and human-computer interaction at Washington University in St.Louis and worked as a research assistant in attention/performance and sensory-interface laboratories. Her design interests connect research on perception with human interaction.

Born in Hong Kong and raised in San Francisco, Winnie has called the Bay Area home her entire life. Her roots in the city have shaped her appreciation for innovation and community values. Administrative team member at Reach Capital. Her biography describes a career as an executive assistant in venture capital, supporting investment teams and the people building new companies. The current directory uses the title Admin; an investment role is not inferred.

Maria is a passionate advocate for the belief that education, socioeconomic mobility, and excellent health are the most powerful tools for universal opportunity. As a dedicated team member, she is known for her exceptional customer service, consistently going above and beyond to welcome and support everyone who interacts with Reach. Administrative team member at Reach Capital. Her published biography describes customer-service and hospitality work supporting founders, visitors and the firm’s community. She advocates for access to education, health and socioeconomic opportunity.

From reading Magic Treehouse books as a child to learning about different cultures in person, Valentina loves exploring. She was born in Colombia and raised in Florida, navigating two cultures and a new education system. Learning to access new opportunities shaped her view on accessibility and inspired her to create positive social and environmental change. Marketing Associate at Reach Capital. She studied at the University of Southern California’s Iovine and Young Academy, combining design, technology and entrepreneurship with an interest in social entrepreneurship and human-centered design.

Dehong was born in China and immigrated to San Francisco at the age of 12. His academic journey was challenging, marked by nearly dropping out of high school due to language barriers and a three-year pause to serve in the military. Despite these obstacles, he persevered and graduated from Golden Gate University with a Master’s in Accountancy, becoming the first member of his family to earn a college degree. Controller at Reach Capital. He earned a master’s degree in accountancy at Golden Gate University and previously worked as Assistant Controller at Lateral Investment Management, Senior Finance Manager at True Capital Management and Senior Audit Associate at RSM US.

Senior Associate at Reach Capital. Previously an AI software engineer and product manager at Google, he spent six years building AI features across Search and Android. He applies technical and product experience to companies developing new operating models and tools for work.

Born and raised in the Bay Area, Amanda developed an early love for math, history, and art while attending public school, a combination that nurtured both her analytical and creative thinking. After earning a degree in marketing, she began her career in sales—a brief and unfulfilling chapter that ultimately led her to discover her true calling in venture capital while pursuing her MBA in 2007. Head of Investor Relations at Reach Capital, supporting relationships with limited partners. Her background includes marketing, communications and venture fundraising. She began pursuing venture-capital work while earning an MBA in2007.

Born in Hong Kong and raised in Los Angeles, Tony thought that simply doing well in school would equate to doing well in life. That was true up to a certain extent, until he tried academia and realized it wasn’t quite the right environment for his more creative aspirations. Head of Platform at Reach Capital. His founder experience includes an education mathematics game and education-technology journalism outlet EdSurge. At Reach he supports early-stage founders and shares practical experience through the firm’s research and communications.

Principal at Reach Capital focused on healthcare opportunities. She studied applied and computational mathematics and statistics at the University of Notre Dame, worked in investment banking at Bank of America and invested in growth-stage companies at Adams Street Partners before Reach.

Jim is an accidental entrepreneur and an even more accidental investor. After graduating from Stanford, he was driven to make a difference in the world and took to being a public high school teacher. His classroom was a lively, noisy testament to the power of hands-on learning, which he later codified as History Alive! when he co-founded Teachers’ Curriculum Institute, which he operated for 16 years. Two subsequent education startups later, he joined Reach as a venture partner to help like-minded founders pursue their mission. Venture Partner at Reach Capital. A Stanford graduate and former public high-school teacher, he co-founded Teachers’ Curriculum Institute and developed its History Alive curriculum. He operated that business for sixteen years and subsequently built other education companies before becoming a venture partner.

Josh was born and raised in a small town in upstate New York. Moving from that small town to a career in public accounting (Deloitte) in the Bay Area gave him insights into a whole new world of ambition and the amazing people trying to make the world a better, more interesting place to live. He found his professional calling when auditing one of his first clients, a prominent VC firm, recognizing it as a critical engine for building and scaling new ideas. Chief Financial Officer of Reach Capital. His career includes auditing venture, private and public companies at Deloitte, ten years at Venrock beginning in2013, and serving as CFO and CCO at Contrary. At Reach he supports finance operations and fund strategy.

Steve has spent his career at the intersection of education, health, and policy, supporting founders and school systems through periods of major transition. He’s led software implementations in large urban school districts, including the first digital special education platform in post-Katrina New Orleans. Influenced by the impact of strong public leadership, he spent several years recruiting and training hundreds of school superintendents in the critical areas of board governance, collective bargaining, political mapping, media relations, community engagement, and bond measure strategy. Partner at Reach Capital with experience in education, healthcare and public policy. His work includes software implementation in school districts and training school-system leaders. Before Reach, he was an operating partner on Vistria Group’s Knowledge and Learning team. Earlier investments are not automatically attributed to Reach.

Growing up in Orlando, Florida, Jomayra saw firsthand how access — or lack thereof — can shape the opportunities people have in life. That experience sparked a lifelong commitment to expanding opportunity for others. Partner at Reach Capital focused on healthcare and work. Her prior experience includes product and customer roles at BloomBoard and venture investing at Emerson Collective and Cowboy Ventures. Her current biography names work with Stepful, WorkWhile and Manifold. She studied political science and education at Stanford and works from New York.

The son of a Marine-turned-cop dad and stay-at-home mom, James grew up in LA’s public magnet programs, finding his tribe among hardcore science and tech nerds. His love of STEM — for both its elegance and its power to improve lives — was forged during those years: stargazing from his backyard, interning at the LASD/LAPD crime lab, running a hand-coded anime file server off his laptop for otaku friends around the world. Partner at Reach Capital. He studied astrophysics at Yale, taught high-school mathematics through Teach For America and worked in college access and Yale admissions. After earning Stanford graduate degrees in business and education, he joined Reach to support technology founders. This investor is distinct from the existing Jona engineer and Arboretum Ventures associate with the same name.

Born in Buenos Aires, Esteban came to the U.S. at 18 for college and never left. After a few years in Wall Street and private equity, he fell in love with entrepreneurship while managing a pre-seed fund for Latin American startups, inspired by founders he worked alongside with, including those of Patagon (acquired by Santander Bank) and Mercado Libre (NASDAQ: MELI). He later co-founded two gaming startups that pioneered the game development industry in Latin America. Both were acquired — one by Activision and the other by DeNA of Japan. Co-founder and Partner of Reach Capital, which he helped establish in2015. Previously an entrepreneur in Latin American game development, he co-founded two gaming businesses acquired by Activision and DeNA. His current investment focus includes AI’s effect on work and labor.

Co-founder and Partner of Reach Capital. She began working at NewSchools Venture Fund in2005 alongside the other founding partners, developing experience in education entrepreneurship and technology. She supports early-stage founders building tools for learning, health and work.

Co-founder and Partner of Reach Capital. Previously a public-school history teacher for seven years, she earned a Stanford education master’s degree and spent nearly a decade developing venture-investment experience before founding Reach. Her investment interests connect learning technology with access to opportunity.

Issuer September 2025 identifies Missy as co-founder and advisor, previously at Google, Amazon, federal health agencies and Canvas Ventures. This advisory position is distinct from full-time employment; current tenure not reconfirmed.

Issuer September 2025 names Srini Rudraraju as founding-team engineering leader, previously at UnitedHealth Group and Dell. Linked profile identifies Srinivas Raju Rudraraju. Current tenure not reconfirmed.

Issuer September 2025 names Vamsi as a founding-team member and technical implementation leader, previously at UnitedHealth Group and ADP. Current tenure not reconfirmed.

Issuer September 2025 names Mike Espy as a healthcare technology sales executive. Current tenure not reconfirmed.

Issuer September 2025 names Terry as Head of Partnerships, previously at Pager, Oura, Blue Spark Technologies and Salesforce. Current tenure not reconfirmed.

Julian Gutierrez is named in the current Penguin Ai author directory.

Glenn Herzberg is named in the current Penguin Ai author directory.

Jake is an engineering leader with more than five years in senior roles at AI/ML companies and a longer history of executive leadership across Bay Area startups. He was most recently VP of Engineering at AMESA, a platform that lets non-programmers train deep reinforcement learning models on their own expert skill sets, and earlier led several engineering and QA teams at Amazon Music. His recent work centers on using AI coding tools to raise the quality and efficiency of the code they produce, and on building strong AI products without runaway token costs.

Nate is a healthcare revenue leader with more than 15 years building and scaling commercial organizations, most recently as Chief Strategy Officer at Surgical Information Systems. He previously held senior sales leadership roles at Surgical Notes, Intelligent Medical Objects, iMedX, and Ingenious Med, spanning revenue cycle management, clinical terminology, and EMR/PM technology.

Dan is a healthcare product leader with 20+ years building and commercializing technology across payer, provider, and digital health markets, with senior roles at RevelAi Health, Best Buy Health, Clinicient, Philips Healthcare, and Intellectual Ventures. He holds an MBA and an MS in Biomedical Engineering from the University of Washington, along with a BSE in Biomedical Engineering.

Abigail is a healthcare strategy and operations leader with experience spanning commercial strategy, revenue operations, and technology across payer, provider, and digital health markets, most recently leading Technology Strategy at SCAN Health Plan. She previously led Healthcare Commercial Strategy at Afiniti and held earlier roles at Kaiser Permanente's Transformation Office and Accenture's Digital Strategy Practice, building expertise across healthcare delivery and strategic consulting.

Niki is a practicing family physician with nearly two decades of primary care experience, a Stanford-trained data scientist and MBA, and a former health plan Chief Medical Officer who has worked at the intersection of clinical care, AI, and operations. She has also served as Corporate Medical Director at the Cleveland Clinic and as an advisor to organizations including Creative Destruction Lab, AltaML, and Elevance Health.

Kishore is a hands-on AI leader who built AI capabilities across Risk and Quality, Care Management, Utilization Management, and OptumRx at UnitedHealth Group, generating $250M in annual savings and incremental revenue, with earlier roles at Amazon and American Express. He holds 10 patents at the intersection of AI, healthcare, and operations, has authored five books on machine learning and AI, and holds an MBA from the Indian Institute of Management, Calcutta.

Fawad spent more than a decade running the largest data and analytics organizations in American healthcare, serving as Chief Data Officer at Kaiser Permanente, UnitedHealthcare, and Optum, where his teams supported care for over 60 million members. He was previously Executive-in-Residence at Canvas Ventures, where he helped lead the firm's healthcare AI thesis, and holds an MBA from Northwestern's Kellogg School of Management.

Ihsaan Patel is identified as a Readily co-founder in Y Combinator’s August2024 healthcare-compliance product launch and his own August29,2024 launch announcement alongside Edward Tiong. Those primary posts establish a historical founder affiliation, while Readily’s current YC active-founder directory names Edward Tiong and Wei An Wang. His current operating role, departure date and an exact historical CEO appointment are not established by the reviewed sources.

Salman Tariq is publicly identified by founder Huzaifa Sial as a Careforce AI team member working with Kern Family Health Care on data integration and patient-support workflows. The company also features him explaining AI-agent execution in healthcare. His precise formal title is not disclosed in the accessible primary company sources.

Usama Sha, referred to as Usama Shah in a founder recommendation, supports Careforce AI through BrandingWaves as a marketing manager and content creator. Founder Huzaifa Sial describes his work across social media, blog content, podcasts and AI-agent videos. His self-published profile describes more than seven years of marketing experience. This is explicitly an external marketing collaboration rather than an inferred full-time employee appointment.

Shafkat Haque contributes to Careforce AI’s design and agent-experience work. The company publicly features him explaining how AI coworkers interact with healthcare teams, and founder Huzaifa Sial credits his work bringing Angelica and David to life. His own website describes more than a decade of design and engineering experience at Apple, BlackBerry and other organizations. A collaborator role is recorded without asserting undisclosed employment terms.

Haris Imran is publicly named by founder Huzaifa Sial among new Careforce AI team members. The announcement links his exact professional profile and establishes the affiliation. His specific responsibilities, educational background and appointment day are not disclosed in the accessible primary announcement; unrelated Haris Imran profiles are not merged.

Ali Mirza joined Careforce AI according to founder Huzaifa Sial’s public announcement linking his exact professional profile. That profile lists Wilfrid Laurier University studies and quantitative projects involving statistical modeling and simulation. Older ResourceMill affiliation remains historical context; his exact Careforce responsibilities and appointment day are not disclosed.

Pegah Jahankhah joined Careforce AI according to founder Huzaifa Sial’s public team announcement. Her own public posts discuss healthcare product research and personalized patient journeys that connect data with useful next actions. Older profile headers still name Jack Health; the newer employer announcement establishes the Careforce appointment without inventing an exact job title or start day.

Mahesh Sundaram is a software engineer working at Careforce AI. His own profile describes building human-AI collaboration and lists Arizona State University education. Founder Huzaifa Sial independently names him among the Careforce team visiting healthcare partners. His prior technical recommendations describe frontend and full-stack development, but an exact current employer title is not exposed.

Benjamin Dykstra publicly lists Careforce, previously Helpcare AI, as his current professional affiliation. His own profile lists College of William and Mary studies from 2013 to 2017. The company’s own public employee directory corroborates this affiliation; his precise job title is not exposed.

Mike Miller publicly lists Careforce as his current professional affiliation and University of Waterloo education. Founder Huzaifa Sial names him among the Careforce staff working with Kern Family Health Care on data integration and broader patient-support workflows. His exact formal job title is not exposed in the accessible primary profile.

Manuel Pedroza leads technology strategy and growth at Careforce AI. His own company appointment announcement describes nearly 15 years in community-health and federally qualified health center leadership. He previously led information technology at Clinica Sierra Vista and holds CHIME healthcare CIO and digital-health executive certifications. His historical employer page and award portrait describe his earlier affiliation; the current Careforce appointment takes precedence.

Huzaifa Sial is the founder and chief executive officer of Careforce AI. He previously led healthcare AI work at UnitedHealth and Optum and has more than 14 years of experience developing disease-prediction, patient-engagement and care-delivery software. His public accelerator biography lists a master’s degree in clinical informatics from Northwestern University, four healthcare AI patents and two prior healthcare AI exits.

Jill Sniffen is published by Alto Neuroscience as Vice President, Clinical Operations in its May2026 corporate presentation. This affiliation concerns a clinical-stage precision psychiatry company using brain biomarkers and machine learning for drug development. The presentation provides an authentic named portrait; an expanded individual career biography and later appointment changes were not independently disclosed.

Christopher Martin is published by Alto Neuroscience as Vice President, CMC Operations in its May2026 corporate presentation. This affiliation concerns a clinical-stage precision psychiatry company using brain biomarkers and machine learning for drug development. The presentation provides an authentic named portrait; an expanded individual career biography and later appointment changes were not independently disclosed.

Patricio O’Donnell is published by Alto Neuroscience as Vice President, Translational Medicine in its May2026 corporate presentation. This affiliation concerns a clinical-stage precision psychiatry company using brain biomarkers and machine learning for drug development. The presentation provides an authentic named portrait; an expanded individual career biography and later appointment changes were not independently disclosed.

Michelle Moran is published by Alto Neuroscience as Vice President, Quality Assurance in its May2026 corporate presentation. This affiliation concerns a clinical-stage precision psychiatry company using brain biomarkers and machine learning for drug development. The presentation provides an authentic named portrait; an expanded individual career biography and later appointment changes were not independently disclosed.

Melissa Berman is published by Alto Neuroscience as Vice President, Finance and Accounting, and Controller in its May2026 corporate presentation. This affiliation concerns a clinical-stage precision psychiatry company using brain biomarkers and machine learning for drug development. The presentation provides an authentic named portrait; an expanded individual career biography and later appointment changes were not independently disclosed.

Jonathon Parker is published by Alto Neuroscience as Senior Vice President, Head of Regulatory Affairs in its May2026 corporate presentation. This affiliation concerns a clinical-stage precision psychiatry company using brain biomarkers and machine learning for drug development. The presentation provides an authentic named portrait; an expanded individual career biography and later appointment changes were not independently disclosed.

Josh Brown is New Ventures Lead at Healthworx Studio, the healthcare company-building branch of the Healthworx ecosystem. The studio publishes the person in its current operating team directory. This affiliation does not establish a general-partner appointment at Healthworx Ventures.

Jaime Goff is New Ventures Manager at Healthworx Studio, the healthcare company-building branch of the Healthworx ecosystem. The studio publishes the person in its current operating team directory. This affiliation does not establish a general-partner appointment at Healthworx Ventures.

Emily Queen is New Ventures Lead at Healthworx Studio, the healthcare company-building branch of the Healthworx ecosystem. The studio publishes the person in its current operating team directory. This affiliation does not establish a general-partner appointment at Healthworx Ventures.

Malav Patel is Vice President, Operations at Healthworx Studio, the healthcare company-building branch of the Healthworx ecosystem. The studio publishes the person in its current operating team directory. This affiliation does not establish a general-partner appointment at Healthworx Ventures.

Katherine Martinko is Vice President, New Ventures at Healthworx Studio, the healthcare company-building branch of the Healthworx ecosystem. The studio publishes the person in its current operating team directory. This affiliation does not establish a general-partner appointment at Healthworx Ventures.

Mike Batista is Managing Partner at Healthworx Studio, the healthcare company-building branch of the Healthworx ecosystem. The studio publishes the person in its current operating team directory. This affiliation does not establish a general-partner appointment at Healthworx Ventures.

Nirban Singh is a published member of the Healthworx Ventures team, which invests in healthcare companies. The current official team directory identifies the person by name and publishes an original portrait; a formal investment title and detailed professional biography are not disclosed in the accessible directory.

Healthworx Ventures investor whose own introduction describes joining in August 2022 after work at the World Bank and a healthcare technology startup. She studied economics and international affairs at George Washington University and earned an MBA and an MS in Information Systems at the University of Maryland. Her published work covers healthcare innovation, including maternal health. Her 2022 senior-analyst title is historical; a current formal title is not disclosed in the accessible team directory.

Managing director of Healthworx Ventures, as identified in the platform’s August 2025 interview with accelerator head Soo Jeon. Her earlier work included corporate venture capital and the 1501 Health healthcare accelerator; the current Ventures directory continues to name her among the team.

Doba Parushev is a published member of the Healthworx Ventures team, which invests in healthcare companies. The current official team directory identifies the person by name and publishes an original portrait; a formal investment title and detailed professional biography are not disclosed in the accessible directory.

Associate at Healthworx Ventures. The platform’s February 2026 promotion announcement describes her joining in summer 2024 after healthcare work at McKinsey. Her work spans investment theses, relationships with startups and healthcare stakeholders, and investment diligence.

Managing partner at Healthworx, the healthcare investment platform originally launched within CareFirst. RAAPID’s April 2026 primary financing announcement identifies his managing-partner title and quotes him on the investment in healthcare AI and risk adjustment. The current Healthworx Ventures directory also publishes him as a team member.

Pamela Louise Rockley is the chief compliance officer of Lightswitch Capital Management, L.P., as confirmed by its March2026 SEC adviser filing. FINRA identifies her as president of Compliance Directives LLC, a compliance consulting business, and describes her compensated chief compliance and anti-money-laundering officer services for investment firms. Her Lightswitch affiliation is a regulatory and compliance role, rather than an investment-partner appointment. An authentic public portrait was not located.

Bo Cui is chief operating officer of Lightswitch Capital Management, L.P., according to its current SEC adviser filing. His published biography describes experience in private equity and cross-border mergers and acquisitions, including senior roles at BrightSphere Investment Group and CCB International. He earned a law degree from Georgetown University Law Center and studied mathematics and computer science at the University of Illinois at Urbana-Champaign. His current issuer biography also identifies him as chief legal officer of High-Trend International Group.

Wei An Wang is Readily’s co-founder and CTO, identified in its current Y Combinator company profile. His publicly published YC biography states that he is building in AI; a more detailed education or career history was not available in the reviewed primary sources.

Edward Tiong is Readily’s co-founder and CEO, confirmed by its Y Combinator and CHCF profiles. He studied AI at Berkeley and previously worked as a machine-learning engineer at AKASA and a data/applied scientist at Microsoft AI. CHCF describes his work on personalized Smart Reply for Outlook. YC describes him as a three-time founder and holder of two patents.

Scientist and strategist working in venture investing at Boost VC. Previously at Trinity Life Sciences, F-Prime Capital and Castle Island Ventures; Brown University alumnus.

Finance leader and systems builder at Boost VC. Previously at Sydecar, On Deck and Juniper Square; Santa Clara University alumnus.

Supports founders and builds the Boost VC community. Previously at 500 Startups and Altitude; holds a biology degree from Washington State University.

Executive assistant and office manager at GreatPoint Ventures, with published experience supporting founders and executives.

Executive assistant at GreatPoint Ventures. Her published background includes support roles at Kleiner Perkins, Apple and NeXT.

Operations manager at GreatPoint Ventures. His published professional background includes fund administration at Standish.

Lee Greening is finance director at Insiders VC, according to its current official six-person team directory. He previously served as finance director at FACEIT, corroborated by the founder-compensation research published by Index Ventures. His current role supports the venture platform’s financial operations; he is not described as a general partner or investment committee member without primary proof.

Partner at GreatPoint Ventures, with a published joining year of 2021. His investment work includes healthcare infrastructure and payer/provider workflows. He studied mathematics and economics at Kenyon College.

Mirta Rotondo is brand and experience director at Insiders VC. She is a design leader and branding adviser who previously built and led a40person experience design team at TrueLayer. Her own biography describes building Mindmapp, an AI-assisted emotional organisation product, and design leadership work across branding and product experience. She holds qualifications in art direction from IEDRome and illustration from the Academy of Art University inSanFrancisco.

Partner at GreatPoint Ventures, with a published joining year of 2023. His investment background includes IAC and a focus on vertical software, marketplaces and financial technology.

Cecilia Braggiotti is venture partner at Insiders VC, an operator, investor and adviser with experience across technology, healthcare and consumer businesses. Her earlier career included McKinsey, private equity, hedge funds and AIcompanyAfiniti. ArsenaleGroup’s own biography records degrees from CassBusinessSchool, LondonBusinessSchool and INSEAD, plus Stanfordexecutivestudy. Her outside board and advisory affiliations are separate from institutional venture cash and do not automatically identify Insiders portfolio investments.

Partner at GreatPoint Ventures, whose biography says he joined in 2022. His entrepreneurial background includes founding and leading Dispatch and earlier work with GreatPoint Energy. Historical outside affiliations do not establish separate current roles or personal investments.

Chief operating officer of GreatPoint Ventures. Her published responsibilities span finance, legal matters, fund administration, human resources and investor relations. Her career background includes Timshel.

Jeff Forrest, also known professionally as Jeffrey Forrest, is investment partner at Insiders VC in London. His self-published professional profile confirms the exact manager affiliation and London Business School study from2020 to2022. His own posts describe supporting venture investments including enterpriseAIcompanyTwin1. He is distinct from the similarly named recording engineer, CGIconsultant and other financial professionals; unverifiable prior-employer details are omitted.

Michele Attisani is co-founder and general partner of Insiders VC. He co-founded FACEIT, helped build its gaming community and international business, and participated in the2022 transaction creating ESL FACEIT Group. His earlier founder career and personal angel investments are distinct from the current venture platform’s institutional investments. Insiders provides operating support to early-stage founders across AI, software and other technology businesses.

General partner of GreatPoint Ventures. His own biography says he joined in 2021 and invests in enterprise AI and automation, data infrastructure, financial technology and commerce infrastructure. Previous roles include Green Bay Ventures, CapitalG and Goldman Sachs.

Niccolo Maisto is co-founder and general partner of Insiders VC. He co-founded gaming platform FACEIT with Michele Attisani and helped scale it to more than30million users. FACEIT combined with ESL in2022 to form ESL FACEIT Group in a transaction the firm describes atUSD1.5billion; that historic company transaction is not capital raised by Insiders. He now supports early-stage founders using operating and company-building experience.

GreatPoint Ventures managing partner with a focus on enterprise computing and the intersection of computer science and life sciences. His published background includes founding CAPP Medical, CiberMed and Xsigo, and early technology leadership at Juniper Networks.

GreatPoint Ventures Partner Emeritus. His published career includes leading Oracle as president and chief operating officer, followed by fourteen years at Kleiner Perkins. Other company and nonprofit affiliations in his biography are career context rather than separately verified current roles.

Tracks technologies and companies addressing societal AI risks across governance, labour, security and public trust. Organises fund events, investment communications and startup discovery.

Leads research into existential and biological risks from advanced AI while managing fund operations and portfolio tools. Previously led product at Academy College Prep.

Ellen M. Zane is a Boston Scientific board director, appointed inApril2016. She is chief executive emeritus of Tufts Medical Center and founding chair of Tufts Medicine, with earlier hospital-system leadership at Mass General Brigham and Quincy Hospital. She studied audiology and speech-language subjects at George Washington and Catholic University.

David S. Wichmann is a Boston Scientific board director, appointed inJune2021. He previously led UnitedHealth Group as chief executive and served in financial and operating leadership roles there, with earlier experience at Arthur Andersen and Advanced Machine Company. He studied accounting at Illinois State University.

Cathy R. Smith is a Boston Scientific board director, appointed inFebruary2026. She is chief financial officer of Starbucks and previously held financial leadership roles at Nordstrom, Bright Health and Target. Her education includes UC Santa Barbara and the University of Southern California.

Cheryl Pegus is a Boston Scientific board director, appointed inMay2024. A cardiologist, she leads FlyteHealth and has earlier strategic-investment, clinical and operating leadership experience at Morgan Health, Walmart, Cambia, Walgreens, Johnson & Johnson, Aetna and Pfizer.

Edward J. Ludwig is a Boston Scientific board director, appointed inMarch2014. He previously led Becton Dickinson as chief executive and board chairman and has finance and medical-technology governance experience. He studied economics and accounting at the College of the Holy Cross and business at Columbia.

Susan E. Morano is a Boston Scientific board director, appointed inJune2023. Her earlier career includes Johnson & Johnson MedTech business development, strategic operations, finance and transaction leadership. She holds degrees from Villanova and Columbia.

Jessica L. Mega is a Boston Scientific board director, appointed inJune2023. A cardiologist and co-founder of Verily, she previously led its medical and scientific work and directed cardiovascular clinical research at Harvard and Brigham & Women’s Hospital. She studied at Stanford, Yale and Harvard.

Stephan Mabry is the named author of Qualified Health’s September2026 article on data pipelines for healthcare AI. His work discusses clinical-data integration, data semantics, operational freshness and architectures supporting model training, evaluation and inference. His matching professional profile reposts the article as his own work. The publication proves a technical contributor relationship; a precise company employment title and authentic portrait were not independently verified.

Melissa Wenk is listed by Qualified Health among its publicly associated employees and confirms joining the team in her own professional post. She describes work with health-system leaders and product launches, as well as earlier experience at the Advisory Board and Kraft Foods. Her precise current job title and authentic public portrait were not independently verified, so no executive seniority or tenure date is invented.

James Yu is a healthcare data integration professional publicly associated with Qualified Health. His own profile describes more than twenty years connecting clinical data systems and identifies business studies at the University of North Carolina at Chapel Hill. An indexed self introduction states that he joined Qualified Health as data integration manager following its March2026 financing. His matching profile and company employee listing distinguish him from other software professionals and physicians with the same name. An authentic public portrait was not verified.

Mike Higgins is listed among associated employees on Qualified Health’s own public company page, linked to the Michael R. Higgins professional profile. A current official biography, precise operating title and authentic public portrait were not accessible in this audit. This identified association is retained with explicit qualifications and is not merged with the similarly named Arizona insurance broker or other unrelated professionals.

David Habiger is a Boston Scientific board director, appointed inJuly2024. He is vice chairman and former chief executive of J.D.Power, with earlier technology-company leadership, venture investing and private-equity advisory experience. He studied at St.Norbert College and the University of Chicago.

Kenneth Stein is senior vice president and global chief medical officer of Boston Scientific, appointed inFebruary2023. He oversees clinical, medical-safety and medical-affairs work and previously served as chief medical officer for rhythm management. He is a cardiac electrophysiologist with earlier Cornell medical faculty experience and degrees from Harvard and NYU.

Stephen Morse is senior vice president and president, Asia Pacific, at Boston Scientific, a role held sinceMay2022. His earlier positions include leading Japan operations and cardiovascular and rhythm-management businesses. He joined the company in1998 after serving in the US Air Force and holds engineering, management and financial-economics degrees.

Jodi Euerle Eddy is senior vice president, Enterprise Services and Digital Officer, at Boston Scientific. She oversees enterprise technology, digital health, artificial intelligence, analytics, cybersecurity and business services. Earlier she held information-systems leadership positions at General Electric. She studied computer science at Southern Connecticut State University.

Rosaleen Burke is senior vice president, Global Quality and Regulatory, at Boston Scientific. She has held this role sinceFebruary2017 and previously directed divisional and international quality activities. She joined the company in1997 and studied biotechnology, microbiology and biochemistry inGalway and business at Oxford Brookes.

Xavier Bertrand is senior vice president and president, Europe, Middle East and Africa, appointedDecember1,2024. His career includes Boston Scientific regional leadership, Medtronic, ATS Medical, Biosensors and managing Symetis before its acquisition. He studied finance at KEDGE Business School.

Charlie Attlan is senior vice president, Strategy and Business Development, at Boston Scientific. His responsibilities include corporate strategy, acquisitions, divestitures, joint ventures, licensing and venture-capital and minority investments. His earlier investment-banking career includes Credit Suisse and BT Alex Brown; he studied economics and mathematics at Princeton.

Paudie O’Connor is executive vice president, Global Operations, overseeing supply chain, quality, regulatory affairs, enterprise services and research operations. His earlier career includes engineering, operations and supply-chain leadership. He studied mechanical engineering at Trinity College Dublin and industrial engineering at University College Dublin.

Miriam O’Sullivan is senior vice president and chief human resources officer of Boston Scientific, appointed inJanuary2025. She directs global people operations, rewards and talent development. Her earlier career includes Boston Scientific manufacturing and supply-chain human resources, IBEC and UCB Pharma; she studied at the University of Limerick.

Jonathan R. Monson is executive vice president and chief financial officer of Boston Scientific, appointed inJune2025. He oversees finance, treasury, tax, audit, investor relations and corporate business development. His previous roles include investor relations, global controller and chief accounting officer; he is a College of the Holy Cross graduate and certified public accountant.

Joseph M. Fitzgerald is executive vice president and group president, Cardiovascular, overseeing global heart therapies and peripheral interventions. His Boston Scientific career includes leadership of cardiology, rhythm management, electrophysiology and neurovascular businesses.

Arthur C. Butcher is executive vice president and group president, MedSurg and Asia Pacific, overseeing businesses including neuromodulation, endoscopy and urology. He joined Boston Scientific in1997 and previously led endoscopy and regional operations. A September2026 SEC disclosure announces retirement from this executive role effectiveJanuary1,2027; that future transition has not occurred as ofOctober7,2026.

Vance R. Brown is executive vice president, general counsel and corporate secretary of Boston Scientific. He leads its legal and compliance functions and previously directed international legal teams, venture-capital transactions, mergers and corporate governance. Earlier he practiced at Skadden; he studied at Western Ontario and Harvard Law School.

Supports regulated technology businesses with international growth, policy and market entry. Previously held leadership roles at Coinbase, Kraken and OKX and senior legal roles at Morgan Stanley.

A technical researcher with experience in blockchain implementations at Genesis Trading, connecting protocol engineering to practical uses and safety.

Previously invested at Radian Capital. Supports companies in strategy, corporate development, go-to-market and navigating complex and regulated markets.

Previously entrepreneur in residence and general manager in Intel’s corporate incubator, where he ran deep-tech ventures. Co-founded and led Consumer Physics, which developed a handheld near-infrared molecular sensor.

Previously a Managing Director at CPP Investments and Partner at Sequoia Capital Global Equities, with growth equity, venture and crossover investment experience. Holds an MBA from Harvard and computer science and management science degrees from Stanford.

Former Managing Director and Co-Head of the Tech Investment Group at GIC, where he built a global venture program. Founded Sentinel Global and its research and adoption platform Sentinel Labs.

Supports the partnership and office, with administration experience across private equity, consumer goods and venture capital.

Leads finance and administration, bringing fund operations, financial management and reporting experience from Connect Ventures and Kindred Capital.

Previously invested at Lightspeed, Target Global and Summit Partners. Co-founded YPlan, acquired by Time Out Group, and works with early and growth-stage technology companies.

An early MuleSoft commercial hire in Europe, with experience in sales, customer success and strategy through IPO and acquisition. Helps technical founders build go-to-market functions.

Founder & CEO of FunPlus, a global leader in interactive entertainment with $1B+ annual revenue. Early personal investor in Moonshot AI, xAI, Anthropic, OpenAI, Databricks. Current affiliation is published by the AGI House platform; guest-speaker lists and personal investments are not automatically manager or individual participation records.

Builds the software and AI systems that power AGI House's platform and programs. Harvard researcher with a background in physics-informed machine learning. Current affiliation is published by the AGI House platform; guest-speaker lists and personal investments are not automatically manager or individual participation records.

Runs operations and partnerships across AGI House's events, programs, and enterprise relationships. Cornell alum and member of Global Women in VC. Current affiliation is published by the AGI House platform; guest-speaker lists and personal investments are not automatically manager or individual participation records.

Leads AI engineering and research at AGI House, building the platform behind its community, events, and labs. MIT alum, ex-Google, and previous founder. Current affiliation is published by the AGI House platform; guest-speaker lists and personal investments are not automatically manager or individual participation records.

Founder of Google X (Waymo), Udacity, and Kitty Hawk. Founding Director of Stanford AI Lab. Passionate about AI and autonomous systems. Current affiliation is published by the AGI House platform; guest-speaker lists and personal investments are not automatically manager or individual participation records.

Founder of AGI House, with a mission to accelerate humanity's transition to AGI. Passionate about connecting the world's top AI researchers, founders, and enterprise leaders. Current affiliation is published by the AGI House platform; guest-speaker lists and personal investments are not automatically manager or individual participation records.

Greg has been an avid gamer since he was 6 years old and is especially passionate about the medium’s ability to bring people together and tell unique stories. Before joining Makers, he invested out of SoftBank’s Vision Fund, leading over $1B of transaction volume across Web 3.0, consumer technology, and gaming assets. He started his career as a management consultant at McKinsey & Company, focusing on TMT strategy and Private Equity.

Nathaniel supports the Makers portfolio in branding, go to market strategy, and key hiring decisions across marketing disciplines. His background includes marketing, communications, and oddly, systems design across Gearbox Publishing and Riot Games. He writes a postcard to his mom wherever he goes and frequently imagines how much more he could get done if Pikmin were real. Nathaniel's natural homes are strategy titles, anything Nintendo, and any game that washes away real life with its immersive world.

Joost is considered “the top academic in the $160 billion video games industry.” He teaches at the NYU Stern School of Business and is the author of One Up: Creativity, Competition, and the Global Business of Video Games. Previously, Joost was co-founder and CEO of SuperData Research, a games market research firm acquired by Nielsen in 2018. He publishes a weekly newsletter on gaming, tech, and entertainment called SuperJoost Playlist.

With 10 years of experience in building, growing, and running communities in video games, Alex supports the Makers portfolio with all things community and audience management. After Ubisoft and the start-up studio world, he now helps build scalable strategies befitting the individual projects. As a gamer and self proclaimed "nerd" himself, he loves bringing his insights to help founders build studios with a deep understanding and appreciation of the player.

Lia is a New York-based Growth operator partnering with founders and creators in the UGC space. Prior to working with Makers, she spent five years in early and growth-stage venture capital at Stripes and Primary Ventures, leading investments across consumer and fintech. A lifelong gamer, Lia's entrepreneurial journey began with selling custom user lookups on Neopets and hair mods for The Sims 2.

Jiang focuses on finding and working with founders as well as strategics in Asia and Americas. She’s a passionate gamer, especially excited about the intersection of tech and storytelling, and an amateur creator in multiple forms incl. writing, theater, movies and music. Prior to joining Makers Fund, she worked with consumer and tech companies across US and Asia helping them on strategy, growth and investing.

Donovan has spent the last 20 years in the game media space as he built websites, tools, and unique product services for some of the largest game brands in the world. After serving as President of Curse, he spent time as President of Fandom where he helped drive the mission of serving creators at a massive scale. A lifelong gamer and advocate for community, creators, and ugc, Donovan continues to support game developers in his newest venture, publishing games. As an avid and lifelong gamer, Donovan plays a variety of games but mostly enjoys grand strategy and city-builder style games.

Anna was part of the original business team at Valve that built the Steam platform and led gaming's transition to digital distribution. She spent 6 years leading platform growth, before joining Oculus to run content strategy for the launch of the Rift. Currently, she is the CEO of Bad Robot Games, focusing on the exciting intersection of gaming and linear entertainment. She's also a Venture Partner at Makers Fund, focused on helping portfolio companies across the globe to scale their businesses.

Yoyo focuses on investing in and supporting founders across Asia. She has a passion for otome and party games, as well as K-pop and anime.  Before joining Makers, Yoyo led investments in gaming and consumer tech companies based in Japan and supported overseas teams with their market expansion efforts.

Walter invests in and supports founders across Europe, the Middle East, and India, specializing in mobile free-to-play and PC/console premium studios and publishers. Prior to Makers Fund, he worked at Epic Games, where he shaped strategy for Fortnite Battle Royale and UEFN. He is based in London and originally from Italy. Outside work, Walter enjoys a diverse array of games, but in particular story-driven RPGs and souls-likes.

Tyler spends his time investing in and supporting founders across North America. Prior to Makers, Tyler advised clients across industries on corporate strategy as well as creating, launching, and operating new technology products. A lifelong gamer, Tyler has a passion for all genres but is known to be a horror evangelist. Away from his controller, he is also an avid moviegoer and loves spending time outdoors.

Ryann has spent the past decade partnering with interactive entertainment companies — from PC/console studios to developer tools and virtual sandboxes. He has a particular passion for working with next-generation creators from unconventional backgrounds who are redefining how games are built and experienced. He’s known for his long-term approach to founder support, and ability to navigate both breakout growth and more complex, less visible moments. Ryann oversees Makers Fund’s investment and portfolio efforts in the Americas and splits his time between the U.S. West Coast and Asia. Ryann Lai is a Makers Fund investor named as a director of TribeVR Inc., the legal entity trading as Ramen VR, in its 2021 and 2022 SEC Form D filings. The historical director role does not establish a current Ramen board seat or a personal equity check. His genuine named portrait is published on Makers Fund’s own team page.

Michael has spent the last 15 years helping companies grow and scale overseas in the interactive entertainment and consumer industries. He works with founders building mobile experiences and platforms and is passionate in building high performing partnerships between product and go to market teams. An engineer at heart, he was a Senior Product Director at Tencent and prior to that a Data Scientist working with companies in the entertainment and consumer industries. In his earlier years, he cut his teeth in esports as a competitive Counter Strike player.

Jay has worked in interactive entertainment for the last sixteen years as an industry advisor, focusing on helping early stage and large international firms with their strategies, investments and growth, working globally across Asia, North America, and Europe. A lifelong gamer and advocate for the industry, his passion is in supporting individuals and companies—large or small—who make positive contributions to the rapid growth of interactive entertainment.

Garry brings over 20 years of experience scaling companies across many genres including, Games, B2B Platforms, Media and Web3. Garry enjoys providing tailored advice and support to individuals and companies of all stages and sizes. He engages with our founders across the globe to advise them on all thing’s talent. As a lifelong gamer, he is passionate about helping our founders build their companies with the world’s best talent.

Curtis spends his time finding and supporting founders across Europe and North America. Prior to Makers, Curtis has worked in VC, consulting, and in growth roles at start-ups -focusing on consumer and technology companies. In a past life Curtis played Halo 3 competitively and facilitated sponsorships for some of the earliest eSports creators. He is based out of London but originally from Toronto.

Andrew partners with founders building innovative products, distribution platforms, and business models in games and interactive entertainment. He has a lifelong curiosity about how technology changes the way people work, play, and build communities. In games, he is especially drawn to how technological shifts are amplified by systems design and storytelling — turning new tools into experiences that entertain, teach, connect people, and help them achieve real-world goals. At Makers, Andrew is a board member and close advisor to a global mix of PC, mobile, AI-first, real-money, and crypto-enabled companies. For new investments, he is especially excited by unconventional approaches to entertainment enabled by emerging technology. Outside work and games, you can find him tinkering with half-baked consumer apps, reading fiction, writing Letterboxd reviews, or spending time in the mountains.

Originally from Iceland but currently operating on the west coast of North America, Alli engages with founders and supports portfolio companies across America and Europe. Alli spent his previous eighteen years deep in the trenches of PC online game development. He was part of the original team that shipped EVE Online and scaled up production for EVE and across CCP globally. Afterward, he joined Riot Games as the Development Director on League of Legends and later focused on production for Riot's subsequent games.

Leads Innovation Fund and telehealth communications at CHCF. Previously held communications and public-engagement roles at Interact Communications, California State University Long Beach and healthcare safety-net organizations. Holds Harvard and UC Berkeley journalism qualifications.

CHCF Innovation Fund adviser with Kaiser Permanente and The Permanente Federation operating experience. The CHCF directory contains differing external titles; only the foundation advisory affiliation is recorded as a role.

Ruffin Mitchener is the founder and creator of Brydge Club, an angel investing community, syndicate platform and media brand. Her own instructor biography describes personal angel investing and leading syndicate opportunities for the club’s women investors. She previously worked at Deloitte and as an operator at a consumer fintech startup, and holds an MBA from UCLA Anderson. Her personal investments, community members’ checks and the collective’s investments are distinct attributions.

Healthcare-services and software investor serving as CHCF Innovation Fund adviser. CHCF identifies his Health Velocity Capital affiliation and a healthcare investment career beginning in1992.

CHCF Innovation Fund adviser and healthcare venture investor associated with Polaris Partners in the fund’s own directory. External fund assets are not CHCF fund commitments. Polaris managing partner in San Francisco, focused on healthcare. Joined as an associate shortly after the firm’s1996 founding. The current biography names work with Ajax Health, Neumora, Nomad Health and Sovato.

CHCF Innovation Fund adviser with a healthcare venture-investment background at Maverick Ventures. The fund directory publishes his manager affiliation and selected company board work; those external roles are not automatically treated as currently verified appointments.

Provides CHCF Innovation Fund program support. Previously coordinated administrative support at Telecare Corporation across finance, human resources and information technology. Holds Sonoma State business-administration and marketing qualifications.

Leads communications supporting CHCF Innovation Fund and CalAIM. Previously a health journalist for25years, including KQED, with work published by NPR, Kaiser Health News and JAMA Internal Medicine. Holds a Brown economics degree.

Invests in mission-aligned early- and growth-stage health companies. Previously an investment manager at Acumen America, working across healthcare, financial services and workforce development, and on its Medicaid Innovation Collaborative. Holds Santa Clara accounting and information-systems qualifications.

Directs CHCF Innovation Fund investments and portfolio support. Previously worked in strategy consulting, McKinsey and J.P. Morgan healthcare investment banking. Holds Stanford human-biology and Harvard public-policy qualifications.

Hanneke Smits serves on Wellcome’s investment committee, appointed in2025 for a three-year term. Her investment career spans private and public markets, including chief investment officer of Adams Street Partners, CEO of Newton Investment Management and global head of BNY Investments. The Van Leer Foundation’s own biography describes those BNY roles as previous positions. She holds a BBA from Nijenrode University and an MBA from London Business School, and has led industry initiatives including Level20 and the30%Club.

John-Arne Røttingen is chief executive officer of Wellcome, having joined inJanuary2024, and a member of its investment committee. He leads the charitable foundation’s science and health mission. His investment committee role is a foundation governance affiliation rather than a commercial venture fund management position.

Sandra Robertson serves on Wellcome’s investment committee, appointed in2025 for a three-year term. She founded Oxford University Endowment Management as its CEO and CIO in2007 following14years at Wellcome, latterly as co-head of portfolio management. OUem’s December2025 announcement confirms that Neamul Mohsin succeeded her as CIO inJanuary2025, while she continues as CEO with retirement planned for the end of2026. Older university biographies calling her current CIO are historical.

Girish Reddy is an external member of Wellcome’s investment committee. He founded and led hedge fund investment manager Prisma Capital Partners after a Goldman Sachs career in equity derivatives, where he became a partner. He earned an electrical engineering degree from IIT Madras and engineering and MBA degrees from Cornell. His university’s original alumni biography and portrait establish his identity; historic firm asset figures are not current Wellcome fund commitments.

Diana Noble is a Wellcome governor and investment committee member. She joined the Board of Governors on6November2023. She founded private equity leadership adviser Kirkos Partners and served as CEO of the UK development finance institution CDC from2011 to2017. Earlier she led international operations and treatment-access programmes at the Clinton Health Access Initiative. Her current governance work includes deputy chair of the Bank of England’s Court of Directors.

Cressida Hogg is an external member of Wellcome’s investment committee and an infrastructure and private equity investment leader. She helped establish3i’s infrastructure business and became its managing partner, then led infrastructure investing at the Canada Pension Plan Investment Board from2014 to2018. She chairs BAE Systems and serves as senior independent director of London Stock Exchange Group. These outside positions do not imply employment in Wellcome’s investment division.

Martin Halusa is an external member of Wellcome’s investment committee. He founded Apax Partners’ German platform in1990 and later served as the global firm’s CEO and chairman; those executive offices are historical rather than current Wellcome employment. Earlier roles included president of Swarovski America. The London School of Architecture’s own biography records degrees from Georgetown University, Harvard Business School and the University of Innsbruck. He is distinct from the similarly named German corporate communications executive.

Julia Gillard chairs Wellcome’s Board of Governors and serves on its investment committee. She joined the board on12April2021. She was Australia’s deputy prime minister and first woman prime minister between2007 and2013, and later chaired the Global Partnership for Education. Her health and education governance work includes Beyond Blue and the Global Institute for Women’s Leadership at King’s College London.

Maggy Chan is chief operating officer of Wellcome and a member of its investment committee. She joined as COO inJanuary2025. Her responsibilities cover finance, risk, digital and technology, legal, sustainability and people, supporting the charitable foundation’s operations. The published committee affiliation describes oversight of the endowment investment platform rather than a separate commercial fund partner position.

Tracy Blackwell is an external member of Wellcome’s investment committee. She helped establish Pension Insurance Corporation in2006 and served as its chief investment officer before becoming CEO in2015. PIC’s2025 annual report confirms that she retired as CEO and from the PIC and PICG boards on31December2025; older biographies describing her as current PIC CEO are historical. Her continuing Wellcome committee membership is confirmed by its current public roster.

Richard Gillingwater chairs Wellcome’s investment committee and is a governor of the foundation, appointed to the board on1September2019. His career has included establishing and leading UK Government Investments, chairing the UK development finance institution CDC, serving as dean of Cass Business School and chairing the Open University. His Wellcome affiliation is a governance appointment rather than a claim that he is an investment division employee.

Robert Holl, CFA, is a principal in Wellcome’s investment division. He joined in2012 after qualifying as a chartered accountant at Deloitte. His2024 Oxford Real Estate Society biography identifies responsibility for commercial property investments across direct and indirect assets, including life sciences, student accommodation, hotels and strategic land in public and private markets. The current official Wellcome roster confirms his principal title, and the Wellcome Genome Campus names him on its science and technology advisory group.

Elaina Elzinga, CFA, is a principal in Wellcome’s investments division, overseeing its absolute return and climate strategies. She manages hedge fund and other investments intended to provide low equity-market exposure and uncorrelated returns, and leads investment stewardship and net-zero work. She joined Wellcome in2010 after investment banking and investment management roles at Goldman Sachs. She studied history at Newnham College, Cambridge, and serves on the Cambridge University Endowment Trust board.

Geoffrey Love is a principal in Wellcome’s in-house investment division. He joined in1998. The foundation’s2019 biography described responsibility for venture capital funds, equity long/short hedge funds and direct private and public company stakes. He holds an economics degree from the University of Edinburgh and has served on the Marie Curie investment committee. Wellcome’s current roster confirms his continuing principal affiliation; older responsibility and outside committee descriptions are historical.

Robert Coke is a principal in Wellcome’s in-house investment division. He joined in1999 after training in emerging-market fund management. Wellcome’s original2019 biography described his team’s private equity and residential property investments and his work across emerging-market and industrial-sector investments. He holds an economics degree from the University of Exeter. The current official roster confirms his continuing principal title; older detailed investment responsibilities are identified as historical.

Pragati Dwivedi contributes public product and customer stories for New Lantern and lists the company as her current professional affiliation. She authored its September 2026 worklist seminar and radiology customer articles. Her self-published profile lists University of Toronto Mississauga education; her exact company job title and appointment date are not public.

Rinko Ghosh is listed among AxoNeural’s board directors. Its external-employer caption identifies him as President and CEO of IHP Therapeutics, corroborated by IHP’s own team directory; he is not represented as AxoNeural CEO. A longer AxoNeural director biography is not published in the reviewed team page.

Vidhya Gopalakrishnan, PhD is an AxoNeural director. Its biography describes pharmaceutical development and operations through clinical development and regulatory submission, including earlier Retrotope, Quark Pharmaceuticals, Neuraltus, Jazz, Aerogen, ALZA and Cygnus roles. She earned a chemistry master’s at IIT Madras and a PhD at National Chemical Laboratory, Pune. The BioJiva COO caption identifies an external employer role, not AxoNeural COO.

Elizabeth Sump is listed on AxoNeural’s board. Its biography describes technology-development and strategic-alliance work at Cleveland Clinic, including startup formation, regulatory planning and research consortia; it also identifies earlier health-policy and Armed Forces Institute of Regenerative Medicine commercialization work. She holds an Ohio State University BS. The external Clinic Senior Director caption is published by AxoNeural and not assumed to be a current executive role at AxoNeural.

Michael P. Steinmetz is AxoNeural’s medical adviser. Its biography identifies his Cleveland Clinic neurosurgery chair and Case Western Reserve neurological-surgery teaching roles, with clinical and research interests in complex and minimally invasive spine surgery, trauma and spinal cord injury. He trained at Texas Tech, the University of New Mexico, Cleveland Clinic and the University of Wisconsin.

Vinod D. Labhasetwar founded AxoNeural Therapeutics and serves as Consulting CSO according to its public team directory. He is a Cleveland Clinic professor and endowed chair of nanomedicine whose research spans nanoparticle drug delivery and antioxidant enzyme formulations. His work includes Neupron for neurological injury; NIH lists him as contact principal investigator for AxoNeural’s2021 STTR grant.

Adin Hodovic is a platform engineer at New Lantern, building and operating cloud infrastructure for its medical-imaging software. His own current résumé describes Kubernetes, infrastructure as code, CI/CD, observability and production reliability. He returned to New Lantern on July 1, 2026 after a site-reliability role at AuthZed; his earlier part-time software-development role at New Lantern ran from August 2021 to March 2022.

Aaron Jones publicly lists New Lantern as his current affiliation. His own biography describes over 25 years of network and security engineering experience, including network infrastructure and security certifications. His exact formal employer title is not exposed in the accessible primary profile.

Alec Huang publicly lists New Lantern as his current professional affiliation and Washington University in St. Louis education. His profile also identifies a phage-genome annotation publication. His precise New Lantern role and exact appointment date are not exposed in the accessible primary source.

Ruxandra Stanciu publicly describes being part of the New Lantern team building its AI radiology workflow solution. Her own posts discuss its agentic worklist and imaging functionality. Her exact formal job title and appointment date are not publicly disclosed in the accessible primary source.

Bruno Alves de Faria publicly identifies New Lantern as his current affiliation. His own professional biography describes an information-systems education and software-architecture specialization. His exact current employer title is not exposed in the accessible primary profile.

Kevin Dietz is a New Lantern team member with healthcare technology and technical customer-support experience. His own profile lists Arizona State University education with summa cum laude distinction and describes prior customer-facing healthcare technology work at Lexmark. His exact current title is not visible.

Nathan Gugel publicly lists New Lantern as his current affiliation and describes himself as a Stanford computer-science graduate. His self-published profile describes software work at FullStory and a student haptic-headset project supporting people with visual impairments. His precise current New Lantern job title is not public.

Pranav Kalicheti is a New Lantern team member with a background in quantitative and computational problems. His own profile lists University of Pennsylvania studies from 2016 to 2020 and software projects involving networks, compilers and Android applications. His exact current title is not exposed.

Rohan Kohli publicly lists New Lantern as his current affiliation and recruits engineers for its on-site San Francisco healthcare technology team. His public posts discuss frontend, backend, AI, WebGL and medical-imaging skills; an exact formal employer title is not exposed.

Jonathan Bowley is a New Lantern team member and a health-information technology professional. His own profile describes extensive experience and multilingual work, and his public posts discuss the company’s worklist and imaging deployments. His exact current formal title is not exposed in the accessible primary profile.

Jennifer Starling is a New Lantern team member with a nursing and healthcare-information background. Her own profile describes joining the company and lists registered-nurse and HL7 CDA credentials, along with project-management and scrum training. Her precise current employer title is not public in the accessible profile.

Shiv Gaglani, MD, MBA, is a strategic advisor to Nestwell, appointed in its announcement of the acquisition of Dwelling Health. He helped develop Dwelling’s home-health platform and co-founded Osmosis, a digital medical-education company acquired by Elsevier in2021. Harvard’s published alumni profile describes his engineering coursework and business-school education. The Nestwell affiliation is advisory and does not establish a new executive job or a personal cash investment.

Matthew Trowbridge is a medical advisor to Nestwell. Its current directory describes him as a physician and built-environment health expert, founder of Health Intent Partners and former chief medical officer of the International WELL Building Institute. His work focuses on how the design and operation of buildings affect human health.

Lauren Eggert is a medical advisor to Nestwell. Its current directory identifies her as an associate professor of medicine at UCSF in pulmonary, critical care, allergy and sleep medicine. Her advisory perspective concerns respiratory health and the effects of indoor and outdoor air pollution. The affiliation is advisory rather than an assumed employment role at Nestwell.

Mark Cullen is a medical advisor to Nestwell. Its current directory identifies him as the former senior associate dean for research and founding director of the Stanford Center for Population Sciences. He brings experience studying the health effects of environmental exposures and emphasizes safe living environments as a factor in long-term health. His university background does not establish a new executive appointment at Nestwell.

Malathi Srinivasan is a medical advisor to Nestwell. Its current public directory identifies her as a clinical professor of medicine in primary care and population health at Stanford University. She advises on the connection between home environments and health, including environmental considerations for early childhood development and vulnerable adults. This advisory affiliation is distinct from staff employment by Nestwell.

Ben Parens is the founder and chief executive officer of Nestwell, a home environmental-health platform. He builds tools that combine location-based exposure information with laboratory testing and practical steps for improving a home’s air, water and other environmental conditions. His own writing describes an oversubscribed pre-seed financing closed on February2,2026, and the work leading to the platform’s 2026 launch. The company subsequently acquired Dwelling Health to expand its clinical scoring capabilities and connections to the healthcare payer ecosystem.

Samir Mehta is publicly identified by New Lantern among the executives discussing its all-in-one radiology workflow platform. This identity concerns the New Lantern radiology professional, rather than unrelated executives with the same name. The accessible primary company announcement does not disclose his exact formal title.

Chris Tann is publicly identified by New Lantern among the executives discussing its all-in-one radiology workflow platform. His own demonstrations describe the company’s imaging and reporting features. His exact executive job title is not disclosed by the accessible primary company announcement.

Beth Siron publicly lists New Lantern as her current professional affiliation. The company’s own public LinkedIn directory also identifies her among its employees. Her exact current job title is not visible in the accessible primary profile.

Kevin Shen publicly lists New Lantern as his current professional affiliation and Massachusetts Institute of Technology education from 2015 to 2019. His accessible primary profile does not disclose an exact current job title; no specific engineering or management title is inferred from third-party directories.

Stephen Woodrow works on engineering and team development at New Lantern. His own recruiting announcements describe scaling the product and infrastructure and hiring experienced backend and infrastructure engineers. His self-published profile lists Massachusetts Institute of Technology education. The engineering-leader title describes these published responsibilities; his exact formal employer title is not exposed in the accessible primary profile.

Ibrahim Mohamed is a principal engineer at New Lantern, working on medical-image viewing, web infrastructure and AI software. His own portfolio describes responsibility for viewer engineering, mammography and PET imaging workflows. The company names him as Principal Engineer in its public events programme.

Ryan Chen is Head of Operations at New Lantern. He leads radiology client deployments and works across engineering, product and clinical teams. He presented intelligent worklist routing at the 2026 SIIM Annual Meeting.

Shiva Suri is the founder and chief executive officer of New Lantern. He developed its AI-native radiology workflow platform after watching his mother work through fragmented imaging and reporting software. He leads the company’s product and operating strategy.

Swiss presenter, mental coach and public-awareness advocate. The Guido Fluri Foundation’s 2010–2017 publication identifies her as its brain-tumour awareness ambassador. Her own current website verifies her identity and provides an authentic portrait; continuing foundation affiliation is unverified and no clinical or medical-advisor appointment is inferred.

Swiss historian and author who led the Guido Fluri Foundation-supported Kinderheime Schweiz historical research project. His own curriculum dates building the project website and recording interviews with formerly institutionalised people to 2010–2014. This published project affiliation is historical, not an assertion of current foundation employment.

Former member of the Guido Fluri Foundation’s board. The foundation’s older imprint still names her, but the official Swiss Gazette notice published 1 September 2026 records her withdrawal and extinguished signing authority. Exact effective departure day and a reliably matching portrait are not publicly established.

External media officer for the Guido Fluri Foundation through Branson Kirk, where the current agency directory identifies him as managing director and owner. His foundation contact role is recorded without inferring foundation employment or a personal venture-investment check.

Swiss social educator, former KESCHA leader and Guido Fluri Foundation board member. The foundation’s own account and the Our Faces – Our Stories project describe his work in residential youth support, foster-family care and integration assistance for young adults leaving care. This is the social educator associated with the foundation, distinct from the Swiss politician and attorney Bruno Frick.

Vice-president of the Guido Fluri Foundation’s board, appointed in the December 2024 Swiss Gazette notice under legal name Tânia Maria Fluri-Gomes de Brito Simão. Her own professional profile reports a University of St Gallen doctorate focused on communication for industrial solution providers. Her published foundation work includes the December 2024 Council of Europe conference on child-protection accountability and safeguarding.

Swiss entrepreneur, philanthropist and founder of the Guido Fluri Foundation established in 2010. Leads its work on child protection, schizophrenia support and rare brain-tumour research and patient information. His foundation, rather than an inferred personal check, is explicitly identified as machineMD’s 2022 seed lead investor.

Rose Maher is Qualified Health’s vice president of AI transformation, as identified in its September2026 University of Rochester case study. Earlier company material described her as an engagement manager supporting health-system customers. Her work combines healthcare product management, analytics and implementation. The company’s own staff introduction identifies prior roles at The Health Management Academy and Brightfield. Her authentic named portraitcard is published by the company.

Navid Farzad is a Frist Cressey Ventures managing partner published in Qualified Health’s investor and adviser roster. His earlier work includes Morgan Noble Healthcare Partners, Enhanced Healthcare Partners and healthcare investment banking and advisory roles. His background spans care-delivery investment and company boards. The Qualified relationship is an institutional/advisory affiliation, not a demonstrated personal investment.

Ian Chiang is a Flare Capital Partners partner listed in Qualified Health’s investor and adviser roster. His background includes healthcare company formation, population-health services at CareAllies and consulting at McKinsey. His published investment work includes clinical-care and healthcare AI companies. He studied biological engineering at Cornell and business at Harvard. The institutional relationship is distinguished from a personal check.

Simon Wu is a Cathay Innovation partner published in Qualified Health’s investor and adviser roster. His work focuses on United States software, financial technology, consumer and digital-health investments. He previously worked at VMware and UBS and studied at Berkeley. Representation of Cathay is not treated as a personal investment or company executive appointment.

Patrick Conway is a physician and healthcare executive published among Qualified Health’s advisers. His biography describes Optum leadership, prior executive work at Blue Cross and Blue Shield of North Carolina, and senior roles at CMS and its innovation center. He trained in pediatrics and clinical epidemiology. Published outside employer responsibilities are not converted into company staff or personal investment records.

Matthew Lungren is a physician and clinical machine-learning researcher listed as a Qualified Health adviser. His work spans healthcare AI at Microsoft, Stanford and Amazon Web Services. The company’s live homepage identifies a current Office of the CTO role, while an older expanded biography still calls him Microsoft Health and Life Sciences chief scientific officer. The discrepancy is qualified; neither title is represented as a Qualified Health executive position.

Jared Kesselheim is a managing partner at Transformation Capital with experience in clinical medicine and healthcare technology investing. Qualified Health publishes him among its investors and advisers. He previously invested at Bain Capital Ventures and trained as a physician at Massachusetts General Hospital. His published biography describes medical, business and undergraduate education at Harvard. No personal check is inferred from institutional affiliation.

Mohamad Makhzoumi is NEA’s co-CEO and managing general partner and is published in Qualified Health’s investor and adviser roster. He has spent more than two decades investing in healthcare technology and services at NEA, following roles at Summit Partners and UBS. Qualified Health’s July2026 SEC filing explicitly identifies him as a statutory director.

DJ Patil is a GreatPoint Ventures general partner listed in Qualified Health’s investor and adviser roster. He was the first United States chief data scientist and previously served as Devoted Health’s chief technology officer. His background includes data-science leadership at LinkedIn and RelateIQ, as well as public-sector initiatives. His affiliation is not evidence of a personal cash ticket or an executive role at Qualified Health. GreatPoint Ventures’ legal manager also names Dhanurjay A. S. Patil as a partner in its March 24, 2026 annual Form ADV. He is not listed in the eleven-person website directory; current partner status is supported separately rather than inferred from directory absence. The filing gives January 2023 for partner status without an exact day.

Amir Dan Rubin is Healthier Capital’s founding managing partner and CEO. Qualified Health lists him in its investor and adviser roster. His previous executive roles include One Medical, Stanford Health Care and Optum, with experience in care delivery and healthcare technology. His company biography identifies business and health-services education at Michigan and undergraduate study at Berkeley. No personal investment ticket is inferred from his institutional representation.

Beau Norgeot is co-founder and chief AI officer at Qualified Health. He previously worked on AI products at Elevance Health and clinical AI at Lucid Lane. His doctorate at UCSF combined machine learning and personalized medicine, including methods for protecting identifiable information in clinical notes. He writes the company’s articles on applied AI and platform engineering.

Shantanu Phatakwala is a Qualified Health co-founder and chief commercial officer. His background combines healthcare operations, data science and entrepreneurship. He previously served as Haven’s chief data science officer and helped build Evolent Health and Resolution Health. His published biography describes engineering education and machine-learning training at Stanford.

Kedar Mate is co-founder and chief medical officer at Qualified Health. He previously led the Institute for Healthcare Improvement and has a faculty affiliation with Weill Cornell Medicine. His career includes clinical leadership, international health work and healthcare quality improvement. He contributes clinical expertise to the company’s AI deployment and governance work.

Justin Norden is Qualified Health’s co-founder and chief executive. A physician and AI entrepreneur, he previously founded Trustworthy AI, acquired by Waymo, and invested at GSR Ventures. His published biography identifies a Stanford Medicine teaching affiliation and qualifications in medicine, business, computational biology and computer science. The July2026 SEC filing also identifies him as a director.

Technology advisor specializing in strategy, infrastructure and data analytics; also described as a principal engineer at Nvidia.

Superhero senior advisor and CEO mentor; also described as a senior director at Nvidia. Nvidia title is not a Superhero executive role.

Head of technology and founder-team evaluation at Superhero; its own biography also identifies him as Cactos CTO and prior Eniram CTO/co-founder. The external company role is not transferred to Superhero.

Lynx Financial founder identified in the organizer’s 2020 RESI investor biography. The primary 2024 Sachs European Life Sciences CEO Forum roster identifies him as Managing Partner, Lynx Financial Hong Kong Ltd. The manager’s homepage publishes no leadership titles, so Founder is used without asserting a newly verified 2026 executive title.

Named in Lynx Financial’s own public LinkedIn employee section. Exact job title is not published in the company directory.

Named in Lynx Financial’s own public LinkedIn employee section. Exact job title is not published in the company directory.

Named in Lynx Financial’s own public LinkedIn employee section. Exact job title is not published in the company directory.

Named in Lynx Financial’s own public LinkedIn employee section. Exact job title is not published in the company directory.

Andrew Ong is an embedded engineer whose current professional profile lists Clair Health and describes programming a wearable medical device in C. His engineering background includes embedded systems, electronics, digital signal processing and communications. The published professional descriptor supports this role; a senior management title is not inferred.

Emily Kraus, MD, is a Clair Health advisor, identified in her own attributed comments in the June2026 founder interview. She is a Stanford clinical assistant professor in orthopaedic surgery and a sports medicine physician focused on female athlete health. She directs the Female Athlete Science and Translational Research program. Her advisor comments describe research potential rather than established device efficacy.

Christy Lane, PhD, is an advisor to Clair Health, confirmed in her own public posts about the founders and financing. She is co-founder and co-CEO of FLORA fertility insurance. Her current FLORA biography describes seventeen years as a professor and prior founding experience with health-data company Vivametrica. She is a research and health-technology entrepreneur; her doctorate is not treated as an MD credential.

Haleigh Larson is Director of Partnerships and Communications at Clair Health. Her own public joining announcement and company posts identify her role supporting women’s health partnerships and communications. Further credentials and an exact appointment date have not been independently established.

Abhinav Agarwal is co-founder and CTO of Clair Health. In his direct founder interview he describes a background in wearable hardware and algorithms and the development of physiological signal models for hormone insights. His company-supplied founder photograph also shows co-founder Jenny Duan; Agarwal is the man on the left, and the original photograph is preserved without cropping.

Jenny Duan is co-founder and CEO of Clair Health, developing a wearable and AI models for women’s hormone insights. She studied symbolic systems at Stanford with an interest in AI ethics. Her own announcements describe the company’s founders, research and actual June2026 seed financing. Stanford’s CS25 course directory identifies her by name and links her exact professional profile.

Fabian Thehos is managing partner and co-chief investment officer of Wellcome’s in-house investment division. He joined Wellcome in2006 and previously led public-market investments including public equities, credit and hedge funds. He became managing partner inOctober2024 and co-CIO on1April2025. The original January2026 Wellcome bondholder presentation identifies his photograph and CFA qualification.

Lisha Patel is managing partner and co-chief investment officer of Wellcome’s in-house investment division. She joined Wellcome in2006 and previously oversaw private-market investments, notably property, infrastructure, private equity and venture capital. She became managing partner inOctober2024 and co-CIO on1April2025. The original January2026 Wellcome bondholder presentation identifies her photograph and CFA qualification.

Martin (Marty) Mann is a Venture Partner at Cartan Capital. Its official biography identifies him as a USTA Foundation Advisory Board member leading its South Florida initiative, a founding partner at20/20 Healthcare Partners, and an M&A partner at Foley & Lardner. He studied at Stanford Law School and the Wharton School. Employment and board affiliations are distinct from personal cash investments.

Gordon Bellis is Partner and Chief Financial Officer at Cartan Capital. His official biography describes over35 years in finance, investment banking, investment management, and launching and managing hedge funds. He holds an MBA from UCLA and a master’s degree from the London School of Economics. His earlier funds are not assumed to be Cartan vehicles.

Georgie Sullivan is an Investment Analyst at Cartan Capital. Her official biography describes public health consulting, research and athlete wellness work, including development of an athlete wellness course for University of Nevada Division I students. She is a former Division I alpine skier and holds a public health degree from the University of Nevada, Reno.

CiCi Bellis is Founder and General Partner of Cartan Capital, which she founded in2023 after four years in venture capital. Her official biography describes her former professional tennis career, reaching WTA World No.35, her USTA Board of Directors role, and broadcasting for CBS Sports and Tennis Channel. She holds an MBA from the University of Miami and a business and finance degree from Indiana University.

Hypertype publishes Teenie Fung as CEO and co-founder. She also uses the professional name Teenie Fung Myhrman.

Remos identifies Omkar Nikam as host of its Space to Ground podcast in its June 23, 2026 episode. This published role does not establish a staff employment contract.

His own public professional profile lists Remos Space Systems AB, also confirmed by the company’s public associated-person directory. The accessible primary text does not disclose a formal title.

His public professional profile lists Remos Space Systems AB; Remos also names him in its 2025 team highlights. The accessible primary text does not disclose a formal job title.

Remos’s employee spotlight describes work on partnerships, growth and commercial execution. The public text does not disclose a formal job title.

Remos’s employee spotlight describes work on high-data-rate system integration and customer installations. The public text does not disclose a formal job title.

Remos’s own employee spotlight, reposted on her public profile, identifies her as Administration & Finance Manager.

Remos’s own company post, publicly reproduced in an Orch repost, identifies Ivan Sedelkin as Software Engineer presenting the company’s paper at the November 2025 ESA TT&C workshop.

Remos publishes Christer Andersson as a board member and Earth Observation Expert. The company also identifies him as L Christer Andersson on its LinkedIn page.

Remos publishes Stefan Gardefjord as a board member and former CEO of SSC.

Remos publishes Mustapha Elriz as a board member and identifies him as founder of Satconsult.

Remos publishes Marcus Friman as a board member and identifies his background as co-founder of Netrounds.

Clinical and scientific neuromodulation professional identified in the2019 Medical Device Innovation Consortium workshop as Enspire’s clinical/regulatory director and in the2020 EDEN protocol as a company contact. Current company position is not verified; the recorded role is historical.

Former Enspire DBS Therapy summer intern and neuroscience researcher. Her own professional posts refer retrospectively to the internship; a2025–2026 research publication names the company affiliation. This role is historical, with exact tenure dates unpublished.

Named author with an Enspire DBS Therapy affiliation in research on posterior-fossa spinal-cord stimulation leads, published online in2025 and in2026. This verifies a research affiliation, without inferring a permanent current employment title.

Publicly named as Vince O. in Enspire DBS Therapy’s own employee listing and the manager’s2026 investment announcement posts. Full surname and precise current position require additional primary verification; unrelated people named Vince Owens are not merged.

Named Enspire DBS Therapy employee in the company public professional-network listing. Exact current title and detailed biography are not published in the accessible company listing.

Named Enspire DBS Therapy employee in the company public professional-network listing. Exact current title and detailed biography are not published in the accessible company listing.

Enspire DBS Therapy team member whose own professional profile describes biomedical and clinical-psychology education at the University of Central Florida. Exact current job title is not publicly visible.

Enspire DBS Therapy team member, independently named in the company public employee listing and his own professional profile. Exact current title is not published in the accessible primary profile.

Enspire DBS Therapy team member with a background in business operations supporting bioscience and healthcare startups. Her own profile describes more than20years of operations experience and Baldwin Wallace education; exact current title is not publicly visible.

Medical-device professional affiliated with Enspire DBS Therapy. His own professional biography describes more than15years of device leadership and MIT Sloan management education. Company and manager public posts confirm team affiliation; the publicly visible primary profile omits an exact job title.

Medical imaging and AI entrepreneur associated with Treehub's founder residency. Stanford's 2018 Arterys case study identifies him as that company's founder and CEO. Treehub's current own cohort announcement and its republished founder account identify programme support and a cohort-partner affiliation; this does not establish a fund general partnership. His authentic portrait is published by APIC's AI summit, which describes a historical executive affiliation with X.

Team member publicly named by Treehub founder Mary Minno. Her exact linked personal profile lists Treehub; Giving Connection's own author biography identifies her as a Stanford computer science student in the class of 2029 working on technology and social impact. A precise Treehub investment or employment title is undisclosed.

Bioengineering researcher and team member publicly named by Treehub founder Mary Minno. The exact linked personal profile identifies Stanford bioengineering PhD studies; Stanford's Soh Lab independently lists her as a PhD candidate and publishes her named portrait. The accessible Treehub sources do not disclose an exact job title, tenure or employment arrangement.

Biomedical data science researcher and team member publicly named by Treehub founder Mary Minno. Stanford's own directory identifies her as a PhD student researching explainable AI, clinical data, machine learning and predictive modelling. A precise Treehub investing title has not been confirmed from accessible primary sources.

Team member publicly named by Treehub founder Mary Minno. Stanford Medicine's Moonshot programme independently identifies him as a project lead in hospital medicine; its named portrait establishes the research identity. The exact Treehub job title and employment terms are unpublished, so no general-partner, CFO or full-time staff title is inferred.

Cleveland Clinic neuroscientist with more than25years of preclinical and clinical deep-brain-stimulation research. His lab translates neurostimulation approaches for acquired brain injury and movement disorders. Published2026 disclosures identify Enspire board, advisory and equity relationships; equity ownership is not treated as a cash investment.

Neurosurgeon and neurostimulation researcher at Cleveland Clinic. His research helped establish the Enspire stroke-rehabilitation technology; published disclosures identify his company medical/scientific officer and board affiliations. Cleveland Clinic publishes his physician biography and authentic portrait.

Chief executive of Enspire DBS Therapy, developing investigational DBS for stroke rehabilitation. His own professional profile describes medical-device technologies and implantable stimulation-lead development, with Boston University management education.

Published in Nostetta’s own support roster as a Nostetta Oy parent-company team member who supports the manager and portfolio companies as needed; not an asserted Nostetta Ventures employee or board member.

Published in Nostetta’s own support roster as a Nostetta Oy parent-company team member who supports the manager and portfolio companies as needed; not an asserted Nostetta Ventures employee or board member.

Published in Nostetta’s own support roster as a Nostetta Oy parent-company team member who supports the manager and portfolio companies as needed; not an asserted Nostetta Ventures employee or board member.

Published in Nostetta’s own support roster as a Nostetta Oy parent-company team member who supports the manager and portfolio companies as needed; not an asserted Nostetta Ventures employee or board member.

Published in Nostetta’s own support roster as a Nostetta Oy parent-company team member who supports the manager and portfolio companies as needed; not an asserted Nostetta Ventures employee or board member.

Published in Nostetta’s own support roster as a Nostetta Oy parent-company team member who supports the manager and portfolio companies as needed; not an asserted Nostetta Ventures employee or board member.

Published in Nostetta’s own support roster as a Nostetta Oy parent-company team member who supports the manager and portfolio companies as needed; not an asserted Nostetta Ventures employee or board member.

Published in Nostetta’s own support roster as a Nostetta Oy parent-company team member who supports the manager and portfolio companies as needed; not an asserted Nostetta Ventures employee or board member.

Published in Nostetta’s own support roster as a Nostetta Oy parent-company team member who supports the manager and portfolio companies as needed; not an asserted Nostetta Ventures employee or board member.

Published in Nostetta’s own support roster as a Nostetta Oy parent-company team member who supports the manager and portfolio companies as needed; not an asserted Nostetta Ventures employee or board member.

Built startup ecosystems at MIT and NYU, worked in venture investing and university commercialisation and co-founded Osney Capital.

Known as Josh Walter; has held senior cybersecurity leadership roles and previously worked in financial services.

Financial services and regulatory lawyer with more than 15 years of experience, including eight years as a partner leading the corporate team at Collas Crill LLP.

Assesses investments and supports commercial growth and partnerships. Co-founded Currencycloud and developed its relationship with Visa, which later acquired the business.

Works with management teams on growth strategy and future funding. Was on the founding team at Star, helped MessageLabs expand internationally and founded Armada Ventures.

Oversees portfolio monitoring and reporting and supports origination and investment execution. Previously worked at Estin & Co and Phoenix Equity Partners.

Known as Mike Edwards on the current directory. Works on deal origination, evaluation and execution; previously worked at Rolls-Royce, UBS Investment Bank and Redline Capital.

Oversees operations, investor relations, portfolio development, brand and ESG. Previously held strategic and commercial roles at Christie’s.

Supports governance and international growth, particularly in Asia. Former Head of Asia Pacific at Neuberger Berman, with earlier roles at Fidelity and J.P. Morgan.

Combines operational and investment responsibilities. Previously worked at Freshfields and Lehman Brothers and was Head of Legal for EMEA at Neuberger Berman.

Leads investment strategy in financial infrastructure and enterprise AI. Has more than 25 years of private equity and venture experience, including senior roles at J.P. Morgan and Montagu.

Leads financial reporting, fund operations and impact framework development. Has more than 20 years of pension and investment experience and previously led sustainable investments at Velliv.

Works on portfolio communications, limited-partner reporting, community and events. Holds an MBA from Copenhagen Business School and previously built a zero-waste consulting practice.

Leads portfolio strategy, governance, investment execution and underwriting. Previously invested in supply-chain ventures and led an early-stage Canadian venture fund focused on responsible consumption, food security and health.

Supports founders with commercial scaling, brand and marketing, team development and global expansion. Founded Luxola, which was acquired by LVMH, led Sephora Southeast Asia and later served as Managing Director of LEGO Ventures.

Works on the founder platform, sourcing, fundraising, partnerships and business development. Previously founded an education technology business and advised Nordic technology companies on diversity and inclusion.

Leads fundraising, investor relations, portfolio management, due diligence, partnerships and fund operations. Previously worked in banking and sustainable finance and was a member of a UNEP FI sustainable banking working group.

Jeremy Langsam is Associate at Cleveland Clinic Innovations, according to its current public directory. A longer career biography was not available in the reviewed primary directory.

Todd Schwarzinger is a Partner at Cleveland Clinic Ventures. His own Clinic commentary describes aligning founders’ and strategic investors’ goals and culture and developing concise investment pitches; he publishes perspectives on healthcare technology and venture investing. His MBA credential is published by the Clinic.

Linda Li, CFA is a Partner at Cleveland Clinic Ventures, leading life-science and medtech portfolio strategy and AI-enabled digital-health investing. NeuroTherapia’s own director biography identifies her prior17-year Vickers Venture Partners co-founding-partner and investment-committee career across China, Southeast Asia and the US. She graduated from Peking University, earned a National University of Singapore master’s degree and is completing a doctorate at Johns Hopkins Bloomberg School of Public Health. Kauffman Fellows confirms the same Clinic/Vickers career and educational identity. She is distinct from Remiges Ventures’ Linda Li, whose own biography identifies a Princeton economics BA and Beth Israel leadership-board affiliation. Linda Li is venture partner at Eckuity Capital. Cleveland Clinic Ventures investment professional advising Eckuity on digital health, medical technology and health-system adoption. Distinct from the Remiges investor also named Linda Li.

Linnea Gottlander is Manager, Innovations Governance & Contract Compliance at Cleveland Clinic Innovations, according to its current public directory. The directory publishes credentials JD. A longer career biography was not available in the reviewed primary directory.

Zach Eisen is Senior Principal at Cleveland Clinic Innovations, according to its current public directory. A longer career biography was not available in the reviewed primary directory.

Daniel Lee is Senior Director, Digital Health & Therapeutics at Cleveland Clinic Innovations, according to its current public directory. The directory publishes credentials JD, LLM. A longer career biography was not available in the reviewed primary directory.

Jerry Wilmink is Director, Digital Health at Cleveland Clinic Innovations, according to its current public directory. The directory publishes credentials PhD, MBA. A longer career biography was not available in the reviewed primary directory.

Saqib Sachani, PhD, MBA is Director for Therapeutics and Diagnostics in Cleveland Clinic Innovations’ business-development and licensing team. His2024 Clinic profile describes his journey into commercialization and technology-transfer work; the current directory’s Director title supersedes that older Associate Director caption.

Giedre Ruzgaite is Associate Director, Digital Health & Therapeutics at Cleveland Clinic Innovations, according to its current public directory. The directory publishes credentials PhD, CLP. A longer career biography was not available in the reviewed primary directory.

Partha Paul is Director, Medical Devices at Cleveland Clinic Innovations, according to its current public directory. The directory publishes credentials PhD, MBA. A longer career biography was not available in the reviewed primary directory.

Bill Kolosi is Director, Medical Devices at Cleveland Clinic Innovations, according to its current public directory. A longer career biography was not available in the reviewed primary directory.

Joe Barone is Director, Therapeutics & Diagnostics at Cleveland Clinic Innovations, according to its current public directory. A longer career biography was not available in the reviewed primary directory.

Sonja O’Malley is General Manager, Business Development & Licensing at Cleveland Clinic Innovations, according to its current public directory. The directory publishes credentials MBA, PMP. A longer career biography was not available in the reviewed primary directory.

Shawn Zimmer is Senior Director, Finance at Cleveland Clinic Innovations, according to its current public directory. The directory publishes credentials CPA, MAcc. A longer career biography was not available in the reviewed primary directory.

Robin Crotty is Department Administrator at Cleveland Clinic Innovations, according to its current public directory. The directory publishes credentials MBA. A longer career biography was not available in the reviewed primary directory.

Joseph Rich is Executive Director at Cleveland Clinic Innovations, according to its current public directory. The directory publishes credentials JD, MBA. A longer career biography was not available in the reviewed primary directory. JumpStart’s August2025 board-appointment biography describes nearly two decades leading innovation strategy, venture development, technology commercialization and regional economic-development initiatives. He leads the Clinic’s Ohio BioValidation Fund for early-stage healthcare technology investment. The current Clinic directory’s Executive Director title is retained separately from earlier Managing Partner captions.

Jon David “JD” Friedland is Executive Director of Ventures at Cleveland Clinic Innovations. His healthcare-investment work follows investment banking and life-sciences advisory experience at Wombat Capital, Rothschild, Lazard Frères and Wasserstein Perella. Baleon Capital’s own adviser biography corroborates the full-name/initials identity and prior Henry Schein corporate/business-development and investment-platform work, plus a University of Southern California BS and Wharton MBA.

Michael Austriaco is General Manager, Assessment at Cleveland Clinic Innovations, according to its current public directory. The directory publishes credentials BSBA. A longer career biography was not available in the reviewed primary directory.

Sarah Stamp is General Manager, Engagement at Cleveland Clinic Innovations, according to its current public directory. The directory publishes credentials MBA. A longer career biography was not available in the reviewed primary directory.

D. Geoffrey Vince is Chief of Cleveland Clinic Innovations and Chair of Biomedical Engineering. His research and leadership focus on aligning technology commercialization with clinical and scientific priorities, data and computing sciences. His virtual-histology technology was licensed to Volcano, later acquired by Philips. He earned a medical-sciences/chemistry degree at DeMontfort University and a biomedical-engineering PhD at the University of Liverpool.

Prithraj Punia is an analyst at JobsOhio Ventures, supporting investment evaluation, portfolio analysis, financial modeling and market research. He joined the team in 2025. He earned an economics degree at Purdue University, with political-science and entrepreneurship studies. His direct joining announcement confirms the venture-unit affiliation; a more precise appointment date is not inferred.

Sachi Sanghavi is junior analyst at JobsOhio Ventures, supporting investment processes and research into prospective investments. She joined in 2025 after studying finance with an English minor at The Ohio State University. Her Ohio background spans the Cleveland, Cincinnati and Columbus regions. The exact manager-linked professional identity is distinguished from unrelated namesakes at Johns Hopkins and in India.

Stephanie Ison, also published as Steph Ison, is principal of JobsOhio Ventures. She brings operating, fundraising and acquisition experience from high-growth startups, private-equity-backed technology businesses and strategic consulting. Her background includes regional banking, Krush technology and media businesses, and founding Full Point Consulting in Dayton. She graduated from Wittenberg University.

Tatyana Hower is managing partner of JobsOhio Ventures and has worked with its evergreen venture platform since its 2020 inception. Her earlier career spans commercial banking and venture finance, including an emerging-technology lending group and BioEnterprise, where she helped medical-technology companies secure venture financing and led Medical Growth Fund activities. She graduated from Baldwin Wallace University and participates in the National Venture Capital Association CFO Taskforce.

Mihajlo Dordevic is published by machineMD as Test Engineer. The named role is in the company’s current public staff directory.

Nadine de Bernardi is published by machineMD as UX Design and Usability. The named role is in the company’s current public staff directory.